{"recordsFiltered":48774,"recordsTotal":48774,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&start=32700","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&start=32100","results":[{"registry_id":"NCT06776913","publication_url":"https://clinicaltrials.gov/study/NCT06776913","title":"Randomized Controlled Trial Comparing Adult to Pediatric Colonoscope in Obese Patients.","has_exemption":false,"start_date":"2025-01-06","completion_date":"2025-09-24","has_results":true,"results_due":false,"sponsor_name":"Cleveland Clinic Florida","sponsor_slug":"cleveland-clinic-florida","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06814028","publication_url":"https://clinicaltrials.gov/study/NCT06814028","title":"Transcutaneous Auricular Neurostimulation as a Treatment for Women With Heavy Menstrual Bleeding: A Dose-finding Trial","has_exemption":false,"start_date":"2025-02-14","completion_date":"2025-09-24","has_results":false,"results_due":false,"sponsor_name":"Spark Biomedical, Inc.","sponsor_slug":"spark-biomedical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07015125","publication_url":"https://clinicaltrials.gov/study/NCT07015125","title":"A Randomized Controlled Trial of a Transcutaneous Electrical Nerve Stimulation Device for the Acute Treatment of Migraine","has_exemption":false,"start_date":"2025-06-09","completion_date":"2025-09-24","has_results":false,"results_due":false,"sponsor_name":"Hinge Health, Inc","sponsor_slug":"hinge-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03781765","publication_url":"https://clinicaltrials.gov/study/NCT03781765","title":"Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk","has_exemption":false,"start_date":"2019-06-04","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03610971","publication_url":"https://clinicaltrials.gov/study/NCT03610971","title":"Treatment Free Remission After Combination Therapy With Ruxolitinib Plus Tyrosine Kinase Inhibitors in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation","has_exemption":false,"start_date":"2019-11-19","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"H. Lee Moffitt Cancer Center and Research Institute","sponsor_slug":"h-lee-moffitt-cancer-center-and-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04537013","publication_url":"https://clinicaltrials.gov/study/NCT04537013","title":"A ProSpective, MulticEnter, Concurrently Controlled Clinical Study of Chondro-Gide® ArticUlar Cartilage CoveR for the Treatment of Large Chondral Lesions in the KnEe (SECURE)","has_exemption":false,"start_date":"2020-08-26","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"Geistlich Pharma AG","sponsor_slug":"geistlich-pharma-ag","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05512377","publication_url":"https://clinicaltrials.gov/study/NCT05512377","title":"Brightline-2: A Phase IIa/IIb, Open-label, Single-arm, Multi-centre Trial of BI 907828 (Brigimadlin) for Treatment of Patients With Locally Advanced / Metastatic, MDM2 Amplified, TP53 Wild-type Biliary Tract Adenocarcinoma, Pancreatic Ductal Adenocarcinoma, or Other Selected Solid Tumours","has_exemption":false,"start_date":"2022-12-13","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06947850","publication_url":"https://clinicaltrials.gov/study/NCT06947850","title":"TITLE: Toyos Clinic / A Phase 4 Study to Assess Longer Duration of Treatment With Cenegermin in Moderate to Severe Dry Eye-Associated Neurotrophic Keratitis","has_exemption":false,"start_date":"2023-01-21","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"Toyos Clinic","sponsor_slug":"toyos-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05831449","publication_url":"https://clinicaltrials.gov/study/NCT05831449","title":"A Phase 3, Randomized, Double-Blind, Placebo- and Active-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy","has_exemption":true,"start_date":"2023-05-22","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"Cali Pharmaceuticals LLC","sponsor_slug":"cali-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06280716","publication_url":"https://clinicaltrials.gov/study/NCT06280716","title":"A Multicenter, Randomized, Double-Blind, Placebo-controlled, Phase 3 Trial to Investigate the Efficacy and Safety of Lebrikizumab When Used With/Without Topical Corticosteroid Treatment in Participants With Moderate-To-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2024-04-24","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06508320","publication_url":"https://clinicaltrials.gov/study/NCT06508320","title":"A Phase 2, Randomized, Observer-blind Study to Evaluate the Safety, Reactogenicity, and Immunogenicity in Relation to the Product Attributes of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Adults ≥50 to <65 Years of Age","has_exemption":false,"start_date":"2024-07-15","completion_date":"2025-09-25","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01821690","publication_url":"https://clinicaltrials.gov/study/NCT01821690","title":"Brain Research in Aggression and Irritability Network (BRAIN): Building Evidence-Based Approaches to Managing Traumatic Brain Injury","has_exemption":false,"start_date":"2013-05-15","completion_date":"2025-09-26","has_results":true,"results_due":false,"sponsor_name":"Indiana University","sponsor_slug":"indiana-university","status":"reported","is_pact":true,"days_late":null},{"registry_id":"NCT02875548","publication_url":"https://clinicaltrials.gov/study/NCT02875548","title":"Tazemetostat Rollover Study (TRuST): An Open-Label, Rollover Study","has_exemption":false,"start_date":"2016-08-30","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Epizyme, Inc.","sponsor_slug":"epizyme-inc","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04843046","publication_url":"https://clinicaltrials.gov/study/NCT04843046","title":"Pioglitazone as an Adjunct to Cognitive-Behavioral Therapy for Cocaine Relapse Prevention","has_exemption":false,"start_date":"2021-08-23","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04975841","publication_url":"https://clinicaltrials.gov/study/NCT04975841","title":"Inclusion Body Myositis Treatment With Celution Processed Adipose Derived Regenerative Cells","has_exemption":false,"start_date":"2022-03-10","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"University of Kansas Medical Center","sponsor_slug":"university-of-kansas-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05142241","publication_url":"https://clinicaltrials.gov/study/NCT05142241","title":"Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 2 Talazoparib and Temozolomide","has_exemption":false,"start_date":"2022-07-11","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05729373","publication_url":"https://clinicaltrials.gov/study/NCT05729373","title":"A Phase 2/3, Randomized, Double-blind, Parallel Group, Placebo-controlled, Flexible-dose, Multicenter Study to Evaluate the Efficacy and Safety of SEP-363856 in the Treatment of Adults With Generalized Anxiety Disorder","has_exemption":false,"start_date":"2023-03-08","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05847790","publication_url":"https://clinicaltrials.gov/study/NCT05847790","title":"Remote Pregnancy Monitoring to Improve Access: The REACTIVE Trial","has_exemption":false,"start_date":"2023-05-25","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06192108","publication_url":"https://clinicaltrials.gov/study/NCT06192108","title":"A Phase 3, Randomized, Open-Label Study to Investigate the Efficacy and Safety of Once Daily Oral Orforglipron Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Metformin (ACHIEVE-2)","has_exemption":false,"start_date":"2024-01-10","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06885242","publication_url":"https://clinicaltrials.gov/study/NCT06885242","title":"Efficacy and Safety of Cyclopentolate Microdrops for Cycloplegic Refraction in Children: a Non-inferiority Crossover Randomized Controlled Trial","has_exemption":false,"start_date":"2024-09-06","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Aristotle University Of Thessaloniki","sponsor_slug":"aristotle-university-of-thessaloniki","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06377930","publication_url":"https://clinicaltrials.gov/study/NCT06377930","title":"A Phase 2A, Multicenter, Open-label Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy","has_exemption":false,"start_date":"2024-10-10","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Rapport Therapeutics Inc.","sponsor_slug":"rapport-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06609174","publication_url":"https://clinicaltrials.gov/study/NCT06609174","title":"Artificial Intelligence Electrocardiogram Enabled Mobile Device in Screening Families for Dilated Cardiomyopathy (The AI-SCREENDCM Decentralized Clinical Trial Pilot Study)","has_exemption":false,"start_date":"2024-10-18","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06604871","publication_url":"https://clinicaltrials.gov/study/NCT06604871","title":"Safety Evaluation of the MiniMed™ 780G System Used in Combination With the DS5 CGM in Children 2-6 Years of Age","has_exemption":false,"start_date":"2024-10-29","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"Medtronic MiniMed, Inc.","sponsor_slug":"medtronic-minimed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07118124","publication_url":"https://clinicaltrials.gov/study/NCT07118124","title":"Pediatric Adhesion and New Dermal Approach Study (PANDA)","has_exemption":false,"start_date":"2025-08-15","completion_date":"2025-09-26","has_results":false,"results_due":false,"sponsor_name":"iRhythm Technologies, Inc.","sponsor_slug":"irhythm-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03916419","publication_url":"https://clinicaltrials.gov/study/NCT03916419","title":"A Single-Arm Phase II Study With a Safety Lead-in of Magnetic Resonance-Guided Hypofractionated Adaptive Radiation Therapy With Concurrent Chemotherapy and Consolidation Durvalumab for Inoperable Stage IIB, IIIA, and Select IIIB and IIIC Non-small Cell Lung Cancer","has_exemption":false,"start_date":"2019-06-20","completion_date":"2025-09-28","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06047405","publication_url":"https://clinicaltrials.gov/study/NCT06047405","title":"NIV for Hypercapnic Respiratory Failure: AVAPS vs S/T BIPAP","has_exemption":false,"start_date":"2023-10-07","completion_date":"2025-09-28","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624956","publication_url":"https://clinicaltrials.gov/study/NCT06624956","title":"Prevention and Treatment of Common Hyperglycemia in Surgery (PATCHS): A Randomized, Controlled, Pilot Study","has_exemption":false,"start_date":"2024-09-04","completion_date":"2025-09-28","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02576431","publication_url":"https://clinicaltrials.gov/study/NCT02576431","title":"A Study to Learn How Well the Drug Larotrectinib Works in Adults With Different Solid Cancers With a Change in the Genes Called NTRK Fusion","has_exemption":false,"start_date":"2015-09-30","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03033303","publication_url":"https://clinicaltrials.gov/study/NCT03033303","title":"Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin for Consolidation of First Remission of Patients With High-Risk Neuroblastoma: A Phase II Study","has_exemption":false,"start_date":"2017-01-23","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03542383","publication_url":"https://clinicaltrials.gov/study/NCT03542383","title":"Treatment of Memory Disorders in Gulf War Illness With High Definition Transcranial Direct Cortical Stimulation","has_exemption":false,"start_date":"2017-02-01","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"The University of Texas at Dallas","sponsor_slug":"the-university-of-texas-at-dallas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04139902","publication_url":"https://clinicaltrials.gov/study/NCT04139902","title":"PHASE II NEOADJUVANT STUDY OF PD-1 INHIBITOR DOSTARLIMAB (TSR-042) VS. COMBINATION OF TIM-3 INHIBITOR COBOLIMAB (TSR-022) AND PD-1 INHIBITOR DOSTARLIMAB (TSR-042) IN RESECTABLE STAGE III OR OLIGOMETASTATIC STAGE IV MELANOMA (NEO-MEL-T)","has_exemption":false,"start_date":"2020-06-12","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Diwakar Davar","sponsor_slug":"diwakar-davar","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04198922","publication_url":"https://clinicaltrials.gov/study/NCT04198922","title":"Acalabrutinib for Chronic Graft-Versus-Host Disease","has_exemption":false,"start_date":"2020-12-11","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Fred Hutchinson Cancer Center","sponsor_slug":"fred-hutchinson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05502341","publication_url":"https://clinicaltrials.gov/study/NCT05502341","title":"An Operationally Seamless Phase 2/3 Randomized, Open-label, Multicenter, Active-Controlled Study to Evaluate the Safety and Efficacy of Bictegravir/Lenacapavir Versus Stable Baseline Regimen in Virologically Suppressed People With HIV-1 on Stable Complex Treatment Regimens","has_exemption":false,"start_date":"2022-08-16","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Gilead Sciences","sponsor_slug":"gilead-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05272735","publication_url":"https://clinicaltrials.gov/study/NCT05272735","title":"HBV Vaccination of Healthy Volunteers to Evaluate the Composition of Germinal Centers","has_exemption":false,"start_date":"2022-12-10","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Rockefeller University","sponsor_slug":"rockefeller-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05727878","publication_url":"https://clinicaltrials.gov/study/NCT05727878","title":"A Study to Evaluate Safety and Efficacy of KPI-012 Ophthalmic Solution in Participants With Persistent Corneal Epithelial Defect (PCED)","has_exemption":false,"start_date":"2023-02-07","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Combangio, Inc","sponsor_slug":"combangio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05456295","publication_url":"https://clinicaltrials.gov/study/NCT05456295","title":"Comparative Effect of Carbon Fiber Orthosis Cuff Design on Preference, Comfort, and Mechanics","has_exemption":false,"start_date":"2023-05-17","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"University of Iowa","sponsor_slug":"university-of-iowa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435221","publication_url":"https://clinicaltrials.gov/study/NCT06435221","title":"A Multicenter, Open-Label Study Assessing Long-Term Exposure With Cytisinicline 3 mg TID","has_exemption":false,"start_date":"2024-05-28","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Achieve Life Sciences","sponsor_slug":"achieve-life-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06384157","publication_url":"https://clinicaltrials.gov/study/NCT06384157","title":"A Phase II Double Blind, Placebo Controlled, Randomised, Dose-Ranging Study to Assess the Safety and Efficacy of INDV-2000 Over 3 Months in Treatment Seeking Individuals With Opioid Use Disorder","has_exemption":false,"start_date":"2024-06-10","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"Indivior Inc.","sponsor_slug":"indivior-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06433219","publication_url":"https://clinicaltrials.gov/study/NCT06433219","title":"An Open-label, Multicenter, Randomized Phase 2 Study of the ATR Inhibitor Tuvusertib in Combination With the PARP Inhibitor Niraparib or the ATM Inhibitor Lartesertib in Participants With BRCA Mutant and/or Homologous Recombination deficiency (HRD)-Positive Epithelial Ovarian Cancer That Progressed on Prior PARP Inhibitor Therapy (DDRiver EOC 302)","has_exemption":false,"start_date":"2024-10-30","completion_date":"2025-09-29","has_results":false,"results_due":false,"sponsor_name":"EMD Serono Research & Development Institute, Inc.","sponsor_slug":"emd-serono-research-development-institute-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT01067287","publication_url":"https://clinicaltrials.gov/study/NCT01067287","title":"Blockade of PD-1 in Conjunction With the Dendritic Cell/Myeloma Vaccines Following Stem Cell Transplantation","has_exemption":false,"start_date":"2010-03-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03592173","publication_url":"https://clinicaltrials.gov/study/NCT03592173","title":"Non-Invasive Stimulation for Improving Motor Function in Spinal Cord Injury","has_exemption":false,"start_date":"2013-07-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Kathleen Friel","sponsor_slug":"kathleen-friel","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02204085","publication_url":"https://clinicaltrials.gov/study/NCT02204085","title":"A Phase I/II Trial of the MUC1 Inhibitor, GO-203-2C in Patients With Relapsed or Refractory Acute Myeloid Leukemia","has_exemption":false,"start_date":"2014-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Beth Israel Deaconess Medical Center","sponsor_slug":"beth-israel-deaconess-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03057730","publication_url":"https://clinicaltrials.gov/study/NCT03057730","title":"Acellular Dermal Matrix Combined With Coronally Advanced Flap in the Treatment of Multiple Recession Defects in Thin Versus Thick Periodontal Biotype Population: A Controlled Clinical Investigation","has_exemption":false,"start_date":"2015-08-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Tufts University","sponsor_slug":"tufts-university","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02810704","publication_url":"https://clinicaltrials.gov/study/NCT02810704","title":"Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement: Balancing Safety and Effectiveness","has_exemption":false,"start_date":"2016-12-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT04047992","publication_url":"https://clinicaltrials.gov/study/NCT04047992","title":"\"The Effects of Exoskeletal-Assisted Walking on Seated Balance Using the Indego™\"","has_exemption":false,"start_date":"2018-02-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"James J. Peters Veterans Affairs Medical Center","sponsor_slug":"james-j-peters-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03423199","publication_url":"https://clinicaltrials.gov/study/NCT03423199","title":"Asian, International, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial of Tamoxifen With or Without Palbociclib ± Goserelin in Women With Hormone Receptor-Positive, HER2-Negative Advanced or Metastatic Breast Cancer","has_exemption":false,"start_date":"2018-02-09","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Center, Japan","sponsor_slug":"national-cancer-center-japan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03225547","publication_url":"https://clinicaltrials.gov/study/NCT03225547","title":"Phase II Study of Pembrolizumab and Mifepristone in Patients With Advanced HER2-negative Breast Cancer","has_exemption":false,"start_date":"2018-02-12","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03509558","publication_url":"https://clinicaltrials.gov/study/NCT03509558","title":"Transcutaneous Spinal Stimulation With Intensive Physical Therapy for Locomotion","has_exemption":false,"start_date":"2018-02-28","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03489629","publication_url":"https://clinicaltrials.gov/study/NCT03489629","title":"STaph Aureus Resistance-Treat Early and Repeat (STAR-TER)","has_exemption":false,"start_date":"2018-04-03","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03213652","publication_url":"https://clinicaltrials.gov/study/NCT03213652","title":"NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice)- Phase 2 Subprotocol of Ensartinib in Patients With Tumors Harboring ALK or ROS1 Genomic Alterations","has_exemption":false,"start_date":"2018-04-17","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03532737","publication_url":"https://clinicaltrials.gov/study/NCT03532737","title":"Phase II Non-Randomised Controlled Trial Of Concomitant Immune Check Point Inhibitor With Radiotherapy And Chemotherapy Or Cetuximab In Advanced Non Metastatic Head And Neck Cancer","has_exemption":false,"start_date":"2018-10-07","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Kuwait Cancer Control Center","sponsor_slug":"kuwait-cancer-control-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03915769","publication_url":"https://clinicaltrials.gov/study/NCT03915769","title":"A Phase 2/3, Multicenter, Randomized, Double-blind, Placebo-controlled Study of Oral Ozanimod to Evaluate Efficacy and Long-term Safety in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis","has_exemption":false,"start_date":"2019-06-03","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Celgene","sponsor_slug":"celgene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03844750","publication_url":"https://clinicaltrials.gov/study/NCT03844750","title":"A Phase II Study of Preoperative Immunotherapy in Patients With Colorectal Cancer and Resectable Hepatic Metastases","has_exemption":false,"start_date":"2019-07-22","completion_date":"2025-09-30","has_results":true,"results_due":false,"sponsor_name":"Chloe Atreya, MD, PhD","sponsor_slug":"chloe-atreya-md-phd","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04101539","publication_url":"https://clinicaltrials.gov/study/NCT04101539","title":"A Randomized Trial Comparing Pulmonary Vein Isolation to Pulmonary Vein Isolation + OPTIMA Ablation in Patients Undergoing Ablation for Atrial Fibrillation","has_exemption":false,"start_date":"2019-09-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03518801","publication_url":"https://clinicaltrials.gov/study/NCT03518801","title":"Cannabidiol as an Adjunctive to Prolonged Exposure for the Treatment of PTSD","has_exemption":false,"start_date":"2019-10-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04050436","publication_url":"https://clinicaltrials.gov/study/NCT04050436","title":"A Randomized, Controlled, Open-Label, Phase 2 Study of Cemiplimab as a Single Agent and in Combination With RP1 in Patients With Advanced Cutaneous Squamous Cell Carcinoma","has_exemption":false,"start_date":"2019-10-08","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Replimune Inc.","sponsor_slug":"replimune-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05119842","publication_url":"https://clinicaltrials.gov/study/NCT05119842","title":"Study on the Safety and Effectiveness of APrevent® VOIS Implants for Treatment in Patients With Unilateral Vocal Fold Paralysis (UVFP) - a Two-Part, Open-Label, Non-Randomized Multicenter Study","has_exemption":false,"start_date":"2019-11-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"APrevent Biotech GmbH","sponsor_slug":"aprevent-biotech-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03997305","publication_url":"https://clinicaltrials.gov/study/NCT03997305","title":"AltaValve Early Feasibility Study Protocol","has_exemption":false,"start_date":"2019-12-04","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"4C Medical Technologies, Inc.","sponsor_slug":"4c-medical-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04535713","publication_url":"https://clinicaltrials.gov/study/NCT04535713","title":"GALLANT: A Phase 2 Study Using Metronomic Gemcitabine, Doxorubicin, Docetaxel and Nivolumab as Second/Third Line Therapy for Advanced Sarcoma","has_exemption":false,"start_date":"2020-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Sarcoma Oncology Research Center, LLC","sponsor_slug":"sarcoma-oncology-research-center-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04504604","publication_url":"https://clinicaltrials.gov/study/NCT04504604","title":"TCF-001 TRACK (Target Rare Cancer Knowledge) Study","has_exemption":false,"start_date":"2020-10-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"TargetCancer Foundation","sponsor_slug":"targetcancer-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03914794","publication_url":"https://clinicaltrials.gov/study/NCT03914794","title":"Phase 2 Window of Opportunity Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors","has_exemption":false,"start_date":"2020-10-02","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04219280","publication_url":"https://clinicaltrials.gov/study/NCT04219280","title":"Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome","has_exemption":false,"start_date":"2020-10-02","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04440735","publication_url":"https://clinicaltrials.gov/study/NCT04440735","title":"A First-in-Human, Two-Part, Open-Label, Phase I/II Study of DSP107 in Subjects with Advanced Solid Tumors Including a Dose-escalation Safety Study (part 1) and Preliminary Efficacy Assessment of DSP107 As Monotherapy and in Combination with Atezolizumab (part 2)","has_exemption":false,"start_date":"2020-10-07","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Kahr Medical","sponsor_slug":"kahr-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04362501","publication_url":"https://clinicaltrials.gov/study/NCT04362501","title":"Efficacy of Dupilumab for Patients With Chronic Rhinosinusitis Without Nasal Polyps (CRSsNP): a Randomized Double Blind Placebo Controlled Phase II Study","has_exemption":false,"start_date":"2020-10-15","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Johns Hopkins University","sponsor_slug":"johns-hopkins-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04207346","publication_url":"https://clinicaltrials.gov/study/NCT04207346","title":"Transcranial Magnetic Stimulation to Improve Functioning in Veterans With PTSD","has_exemption":false,"start_date":"2020-12-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04248283","publication_url":"https://clinicaltrials.gov/study/NCT04248283","title":"A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency","has_exemption":false,"start_date":"2021-01-26","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Uromedica","sponsor_slug":"uromedica","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04364256","publication_url":"https://clinicaltrials.gov/study/NCT04364256","title":"Neuromuscular Electrical Stimulation for Physical Function Maintenance During Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2021-05-14","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04903873","publication_url":"https://clinicaltrials.gov/study/NCT04903873","title":"An Open-Label, Phase 1/2 Study to Evaluate Safety, Efficacy, and Pharmacokinetics of EU101, an Agonistic Anti-CD137 (4-1BB) Monoclonal Antibody in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2021-05-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Eutilex","sponsor_slug":"eutilex","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04913272","publication_url":"https://clinicaltrials.gov/study/NCT04913272","title":"A Double-Blind, Randomized, Placebo-Controlled Phase 2 Clinical Trial To Evaluate Safety And Efficacy Of KT-301 (Formerly US-APR2020) In Subjects With Chronic Kidney Disease Stage IV","has_exemption":false,"start_date":"2021-06-24","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Kibow Pharma","sponsor_slug":"kibow-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04950075","publication_url":"https://clinicaltrials.gov/study/NCT04950075","title":"A Randomized, Blinded, Placebo-controlled, Phase 2 Study of INBRX-109 in Unresectable or Metastatic Conventional Chondrosarcoma","has_exemption":false,"start_date":"2021-09-23","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Inhibrx Biosciences, Inc","sponsor_slug":"inhibrx-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05121038","publication_url":"https://clinicaltrials.gov/study/NCT05121038","title":"A Phase 1B/2A Trial of CEND-1 in Combination with Neoadjuvant FOLFIRINOX Based Therapies in Pancreatic, Colon and Appendiceal Cancers (CENDIFOX)","has_exemption":false,"start_date":"2021-10-20","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Anup Kasi","sponsor_slug":"anup-kasi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05111262","publication_url":"https://clinicaltrials.gov/study/NCT05111262","title":"Symptom-driven Combination Inhaled Corticosteroids and Long-acting Beta Agonist Therapy for Patients With Asthma Who Are Identified as Non-adherent to Daily Maintenance Inhalers","has_exemption":false,"start_date":"2021-12-16","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05400798","publication_url":"https://clinicaltrials.gov/study/NCT05400798","title":"A Longitudinal, Multi-Center Safety Study of Autologous Adult Adipose-Derived Regenerative Cell Injection Into Chronic Partial-Thickness Rotator Cuff Tears","has_exemption":false,"start_date":"2022-01-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"InGeneron, Inc.","sponsor_slug":"ingeneron-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05071716","publication_url":"https://clinicaltrials.gov/study/NCT05071716","title":"A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis","has_exemption":false,"start_date":"2022-04-07","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Bausch Health Americas, Inc.","sponsor_slug":"bausch-health-americas-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208047","publication_url":"https://clinicaltrials.gov/study/NCT05208047","title":"A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors","has_exemption":false,"start_date":"2022-04-14","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Cogent Biosciences, Inc.","sponsor_slug":"cogent-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06686693","publication_url":"https://clinicaltrials.gov/study/NCT06686693","title":"Intravenous Iron Prophylaxis for Rapid High Altitude Insertions","has_exemption":false,"start_date":"2022-04-15","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"United States Army Research Institute of Environmental Medicine","sponsor_slug":"united-states-army-research-institute-of-environmental-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05313555","publication_url":"https://clinicaltrials.gov/study/NCT05313555","title":"The Effect of Violet Device Dosed UV-C Exposure on Healthy Hand Skin","has_exemption":false,"start_date":"2022-04-19","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444894","publication_url":"https://clinicaltrials.gov/study/NCT05444894","title":"A Multicenter Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Dose of Autologous Clustered Regularly Interspaced Short Palindromic Repeats Gene-edited Cluster of Differentiation 34 (CD34+) Human Hematopoietic Stem and Progenitor Cells (HSPC) (EDIT-301) in Transfusion-Dependent Beta Thalassemia (TDT)","has_exemption":false,"start_date":"2022-04-29","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Editas Medicine, Inc.","sponsor_slug":"editas-medicine-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04960384","publication_url":"https://clinicaltrials.gov/study/NCT04960384","title":"Fibroblast Growth Factor Regeneration of Tympanic Membrane Perforations","has_exemption":false,"start_date":"2022-05-27","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05666141","publication_url":"https://clinicaltrials.gov/study/NCT05666141","title":"The Effect of Pharyngeal Electrical Stimulation (PES) on Peripheral Biomechanical Aspects of Deglutition","has_exemption":false,"start_date":"2022-06-07","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Universitaire Ziekenhuizen KU Leuven","sponsor_slug":"universitaire-ziekenhuizen-ku-leuven","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05351593","publication_url":"https://clinicaltrials.gov/study/NCT05351593","title":"A Phase I/II Study of Tafasitamab Plus Lenalidomide in Relapsed CNS Lymphoma","has_exemption":false,"start_date":"2022-06-08","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"James Rubenstein","sponsor_slug":"james-rubenstein","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05406622","publication_url":"https://clinicaltrials.gov/study/NCT05406622","title":"A Prospective, Multicenter, Single Blind, Randomized Controlled Trial Evaluating the Safety and Effectiveness of the MOTIV Sirolimus-Eluting Bioresorbable Vascular Scaffold Compared With Plain Balloon Angioplasty for the Treatment of Infrapopliteal Lesions","has_exemption":false,"start_date":"2022-06-10","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"REVA Medical, Inc.","sponsor_slug":"reva-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05400980","publication_url":"https://clinicaltrials.gov/study/NCT05400980","title":"The Expander-2 Trial: A Multi-Center, Randomized, Blinded, Controlled Study to Evaluate the Safety and Efficacy of the Urocross® Expander System and Retrieval Sheath","has_exemption":false,"start_date":"2022-07-05","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Prodeon Medical, Inc","sponsor_slug":"prodeon-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05309421","publication_url":"https://clinicaltrials.gov/study/NCT05309421","title":"An Open Label, Single Arm Trial Evaluating the Efficacy and Safety of EVX-01 in Combination With Pembrolizumab in Checkpoint Inhibitor Treatment naïve Adults With Unresectable or Metastatic Melanoma","has_exemption":false,"start_date":"2022-09-19","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Evaxion Biotech A/S","sponsor_slug":"evaxion-biotech-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05832502","publication_url":"https://clinicaltrials.gov/study/NCT05832502","title":"A Placebo Controlled Clinical Trial Investigating the Safety and Immunogenicity of GBS6 in Pregnant Women With and Without Human Immunodeficiency Virus (HIV) Infection and Their Infants","has_exemption":false,"start_date":"2022-10-14","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"St George's, University of London","sponsor_slug":"st-georges-university-of-london","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04466566","publication_url":"https://clinicaltrials.gov/study/NCT04466566","title":"Effect of Genetic Variation in the GLP-1 Receptor on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetic Humans","has_exemption":false,"start_date":"2022-10-17","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Adrian Vella","sponsor_slug":"adrian-vella","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05500586","publication_url":"https://clinicaltrials.gov/study/NCT05500586","title":"The Effects of Glucagon on Hepatic Metabolism","has_exemption":false,"start_date":"2022-10-20","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Adrian Vella","sponsor_slug":"adrian-vella","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05417932","publication_url":"https://clinicaltrials.gov/study/NCT05417932","title":"A Phase 1/ 2a, Multicenter Study of SCG101 in the Treatment of Subjects With Hepatitis B Virus-Related Hepatocellular Carcinoma","has_exemption":false,"start_date":"2022-10-26","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"SCG Cell Therapy Pte. Ltd.","sponsor_slug":"scg-cell-therapy-pte-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05677282","publication_url":"https://clinicaltrials.gov/study/NCT05677282","title":"A Randomized Controlled Trial Evaluating Single-dose Rifaximin Versus Azithromycin With Loperamide Adjunct for Treatment of Acute Watery Diarrhea","has_exemption":false,"start_date":"2022-10-28","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Henry M. Jackson Foundation for the Advancement of Military Medicine","sponsor_slug":"henry-m-jackson-foundation-for-the-advancement-of-military-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05503225","publication_url":"https://clinicaltrials.gov/study/NCT05503225","title":"Colchicine Use in Intracranial Atherosclerotic Disease - a Pilot Open-labelled Randomized Trial","has_exemption":false,"start_date":"2022-11-28","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05733546","publication_url":"https://clinicaltrials.gov/study/NCT05733546","title":"A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder","has_exemption":false,"start_date":"2023-01-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"COMPASS Pathways","sponsor_slug":"compass-pathways","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05748600","publication_url":"https://clinicaltrials.gov/study/NCT05748600","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Assess the Efficacy, Safety, and Tolerability of Dexpramipexole Administered Orally for 24 Weeks in Participants With Eosinophilic Asthma","has_exemption":false,"start_date":"2023-01-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Areteia Therapeutics","sponsor_slug":"areteia-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05760989","publication_url":"https://clinicaltrials.gov/study/NCT05760989","title":"Edwards EWJ-202 Transcatheter Tricuspid Valve Replacement System: Investigation of Safety and Clinical Efficacy Using a Novel Device in Patients With at Least Severe Tricuspid Regurgitation in JAPAN","has_exemption":false,"start_date":"2023-02-06","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Edwards Lifesciences","sponsor_slug":"edwards-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05561751","publication_url":"https://clinicaltrials.gov/study/NCT05561751","title":"A Phase 2, Randomized, Open-Label Study to Assess the Safety and Efficacy of GPC 100 and Propranolol With and Without G-CSF for the Mobilization of Stem Cells in Patients With Multiple Myeloma Undergoing Autologous Stem Cell Transplant","has_exemption":false,"start_date":"2023-02-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"GPCR Therapeutics, Inc.","sponsor_slug":"gpcr-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05597735","publication_url":"https://clinicaltrials.gov/study/NCT05597735","title":"A Phase III, Multi-country, Randomized, Placebo-controlled, Double-blinded Trial to Assess the Efficacy and Safety of Tecovirimat Antiviral Treatment for Patients With Monkeypox Virus Disease","has_exemption":false,"start_date":"2023-03-03","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"ANRS, Emerging Infectious Diseases","sponsor_slug":"anrs-emerging-infectious-diseases","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05766813","publication_url":"https://clinicaltrials.gov/study/NCT05766813","title":"A Randomized, Double-blind, Placebo-controlled Multicenter Study to Assess the Efficacy and Safety of Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease","has_exemption":false,"start_date":"2023-03-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Intra-Cellular Therapies, Inc.","sponsor_slug":"intra-cellular-therapies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02994498","publication_url":"https://clinicaltrials.gov/study/NCT02994498","title":"An Open-Label Phase I/IIa Dose-Escalation Study Evaluating the Safety, Tolerability and Efficacy of DCB-BO1301 as Add-on Therapy to Dacarbazine in Subjects With Advanced Melanoma","has_exemption":false,"start_date":"2023-03-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Chung Mei Biopharma Co., Ltd","sponsor_slug":"chung-mei-biopharma-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05725018","publication_url":"https://clinicaltrials.gov/study/NCT05725018","title":"A Phase 3b Study for the Treatment of Dystrophic Epidermolysis Bullosa (DEB) in New and Previously EB-101 Treated Patients","has_exemption":false,"start_date":"2023-04-02","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Abeona Therapeutics, Inc","sponsor_slug":"abeona-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05748873","publication_url":"https://clinicaltrials.gov/study/NCT05748873","title":"A Phase I/II Study to Assess the Safety and Tolerability of a Single Subretinal Administration of SPVN06 Gene Therapy in Subjects With Rod-Cone Dystrophy (RCD) Due to a Mutation in the RHO, PDE6A, or PDE6B Gene","has_exemption":false,"start_date":"2023-04-12","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"SparingVision","sponsor_slug":"sparingvision","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05743283","publication_url":"https://clinicaltrials.gov/study/NCT05743283","title":"Efficacy of SynEx™ Wound Rinse in Civilian Surrogates of Combat Injury Wounds","has_exemption":false,"start_date":"2023-04-12","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Synedgen, Inc.","sponsor_slug":"synedgen-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04668326","publication_url":"https://clinicaltrials.gov/study/NCT04668326","title":"Impact of Mobile Manual Standing Wheelchair on Standing Dosage and Utility","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05588648","publication_url":"https://clinicaltrials.gov/study/NCT05588648","title":"A Phase I/II, Open-label, Multicenter Study to Assess the Safety, Tolerability, Pharmacokinetics, and Antitumor Activity of Vactosertib as a Single Agent in Adolescents and Adults With Recurrent, Refractory or Progressive Osteosarcoma","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"MedPacto, Inc.","sponsor_slug":"medpacto-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05838300","publication_url":"https://clinicaltrials.gov/study/NCT05838300","title":"Lexion AP 50/30 Warmed Humidified Real Time CO2 Insufflation vs Airseal Recirculated CO2/Air Insufflation in Minimally Invasive Bariatric (Gastric Bypass) Surgery: A Randomized Controlled Study of Clinical Evaluation","has_exemption":false,"start_date":"2023-05-19","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03607175","publication_url":"https://clinicaltrials.gov/study/NCT03607175","title":"Randomized Clinical Control Trial Comparing the Effects of a Steroid Eluting Implant Versus Triamcinolone-impregnated Carboxymethylcellulose Foam on the Postoperative Clinic Experience in Patients That Underwent Functional Endoscopic Surgery for Nasal Polyposis","has_exemption":false,"start_date":"2023-07-24","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Marina Boruk","sponsor_slug":"marina-boruk","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04203316","publication_url":"https://clinicaltrials.gov/study/NCT04203316","title":"An Open-Label Feasibility Study to Assess the Safety and Pharmacokinetics of Enasidenib in Pediatric Patients With Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) With an Isocitrate Dehydrogenase-2 (IDH2) Mutation","has_exemption":false,"start_date":"2023-08-14","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Children's Oncology Group","sponsor_slug":"childrens-oncology-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05961124","publication_url":"https://clinicaltrials.gov/study/NCT05961124","title":"A Phase II, Single-Arm Trial Assessing Alternative Dosing Of Niraparib To Decrease Dose Interruption In First Line Maintenance Treatment For Ovarian Cancer: Dose Escalation","has_exemption":false,"start_date":"2023-08-21","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Sunnybrook Health Sciences Centre","sponsor_slug":"sunnybrook-health-sciences-centre","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05826990","publication_url":"https://clinicaltrials.gov/study/NCT05826990","title":"Single Group Phase 2 Study to Investigate Pharmacokinetics, Safety and Tolerability of Cefepime-Enmetazobactam Administered by IV Over 2 Hr in Male or Female Participants From Birth to Less Than 18 Years of Age Hospitalised With cUTI","has_exemption":false,"start_date":"2023-09-11","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Allecra","sponsor_slug":"allecra","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06064071","publication_url":"https://clinicaltrials.gov/study/NCT06064071","title":"Clinical Study Evaluating Nordlys™ SWT IPL for Dry Eye Disease (DED) Due to MGD","has_exemption":false,"start_date":"2023-09-18","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Candela Corporation","sponsor_slug":"candela-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06053775","publication_url":"https://clinicaltrials.gov/study/NCT06053775","title":"Intervention With Non-Invasive Brain Stimulation and Cognitive Training for Depressive Symptomatology Associated With Breast Cancer (ONCODEP)","has_exemption":false,"start_date":"2023-09-27","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"University of Santiago de Compostela","sponsor_slug":"university-of-santiago-de-compostela","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05881382","publication_url":"https://clinicaltrials.gov/study/NCT05881382","title":"Phase 3, Randomized, Double-blind, Placebo-controlled, Safety and Efficacy Study of Dutogliptin in Co-administration With Filgrastim in Early Recovery Post-myocardial Infarction","has_exemption":false,"start_date":"2023-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Recardio, Inc.","sponsor_slug":"recardio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06009458","publication_url":"https://clinicaltrials.gov/study/NCT06009458","title":"Clinical Evaluation of Safety and Effectiveness for Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear","has_exemption":false,"start_date":"2023-10-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Acuity Polymers, Inc.","sponsor_slug":"acuity-polymers-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06046729","publication_url":"https://clinicaltrials.gov/study/NCT06046729","title":"A Phase 2b, Double-Blind, Placebo-Controlled Study to Evaluate Eltrekibart in Adult Participants With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2023-10-23","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06013241","publication_url":"https://clinicaltrials.gov/study/NCT06013241","title":"A Phase 2b, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Efficacy and Safety of Brensocatib in Participants With Chronic Rhinosinusitis Without Nasal Polyps - The BiRCh Study","has_exemption":false,"start_date":"2023-10-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Insmed Incorporated","sponsor_slug":"insmed-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03813095","publication_url":"https://clinicaltrials.gov/study/NCT03813095","title":"Nanoencapsulated Cannabidiol Time Released Capsules Targeted to Reduce Cravings in the Treatment of Opioid Addiction","has_exemption":false,"start_date":"2023-10-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Aphios","sponsor_slug":"aphios","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06087276","publication_url":"https://clinicaltrials.gov/study/NCT06087276","title":"Phase 3, Decentralized, Randomized, Double-Blind, Placebo Controlled, Parallel Design, Randomized Withdrawal, and Long-term Safety Study to Evaluate the Efficacy and Safety of Ulixacaltamide (PRAX-944) in Adults With Essential Tremor","has_exemption":false,"start_date":"2023-11-02","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Praxis Precision Medicines","sponsor_slug":"praxis-precision-medicines","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05566769","publication_url":"https://clinicaltrials.gov/study/NCT05566769","title":"Performance and Safety of a Digital Tool for Unsupervised Self-assessment of Neuromyelitis Optica Spectrum Disorder","has_exemption":false,"start_date":"2023-11-03","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Ad scientiam","sponsor_slug":"ad-scientiam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07037888","publication_url":"https://clinicaltrials.gov/study/NCT07037888","title":"Efficacy of Ketorolac for Postoperative Pain Management in Hip Arthroscopy: A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2023-12-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06122662","publication_url":"https://clinicaltrials.gov/study/NCT06122662","title":"A Phase 2b/3 Study of the Safety and Efficacy of AMX0035 in Progressive Supranuclear Palsy (ORION)","has_exemption":false,"start_date":"2023-12-21","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Amylyx Pharmaceuticals Inc.","sponsor_slug":"amylyx-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06277622","publication_url":"https://clinicaltrials.gov/study/NCT06277622","title":"A Prospective Multicenter Cohort Study About Internal Fixation Using Proximal Femoral Universal Nail (PFUN) Versus Proximal Femoral Nail Antirotation (PFNA) for Femoral Intertrochanteric Fracture","has_exemption":false,"start_date":"2024-01-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Peking University Third Hospital","sponsor_slug":"peking-university-third-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06246526","publication_url":"https://clinicaltrials.gov/study/NCT06246526","title":"Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).","has_exemption":false,"start_date":"2024-01-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Saint Francis Hospital","sponsor_slug":"saint-francis-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06297811","publication_url":"https://clinicaltrials.gov/study/NCT06297811","title":"Efficacy and Safety of Trilaciclib in Myeloprotection During Chemotherapy for Advanced/Recurrent Malignant Solid Tumors - A Phase II Study","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Sun Yat-sen University","sponsor_slug":"sun-yat-sen-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06410352","publication_url":"https://clinicaltrials.gov/study/NCT06410352","title":"Effectiveness of Pharmacologic, Surgical, and Dietetic Weight Loss Methods on Lifespan in Patients With Metabolic Syndrome: a Comparative Clinical Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"University Medical Center, Kazakhstan","sponsor_slug":"university-medical-center-kazakhstan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06437223","publication_url":"https://clinicaltrials.gov/study/NCT06437223","title":"A Phase 2 Study to Compare the Efficacy and Safety of Orally Administered Xiflam™ Therapy With Orally Administered Placebo in Patients With Ocular and Systemic Manifestations of Post COVID Sequelae Known as \"Long\" COVID","has_exemption":false,"start_date":"2024-03-12","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Inflammx Therapeutics Inc","sponsor_slug":"inflammx-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05908331","publication_url":"https://clinicaltrials.gov/study/NCT05908331","title":"MagicTouch Sirolimus-coated Balloon for Treatment of In-Stent Restenosis in Coronary Artery Lesions","has_exemption":false,"start_date":"2024-04-16","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Concept Medical Inc.","sponsor_slug":"concept-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06331624","publication_url":"https://clinicaltrials.gov/study/NCT06331624","title":"Biomarker Modulation and the Inhibition of Natural Killer Type 1 (NKT1) Cells by Oral GRI-0621 in Patients With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2024-04-24","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"GRI Bio Operations, Inc.","sponsor_slug":"gri-bio-operations-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06453109","publication_url":"https://clinicaltrials.gov/study/NCT06453109","title":"Towards Treatment of the Complex Patient: Investigations of Low-intensity Focused Ultrasound","has_exemption":false,"start_date":"2024-04-29","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Washington D.C. Veterans Affairs Medical Center","sponsor_slug":"washington-dc-veterans-affairs-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06626165","publication_url":"https://clinicaltrials.gov/study/NCT06626165","title":"Mirikizumab Therapy is Effective for Patients With Moderate to Severe Ulcerative Colitis Patients Whose Geboes Score Grade is ≥3.2) on Endoscopic Biopsy","has_exemption":false,"start_date":"2024-07-20","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Showa Inan General Hospital","sponsor_slug":"showa-inan-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05907941","publication_url":"https://clinicaltrials.gov/study/NCT05907941","title":"Closed Incision Negative Pressure Therapy Compared to Conventional Dressing Following Autologous Abdominal Tissue Breast Reconstruction: A Randomized Control Trial","has_exemption":false,"start_date":"2024-07-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"McMaster University","sponsor_slug":"mcmaster-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06692218","publication_url":"https://clinicaltrials.gov/study/NCT06692218","title":"Leadless Pacemaker Implantation Positions and Its Relationship with Procedure Efficacy and Complication","has_exemption":false,"start_date":"2024-08-05","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Chinese University of Hong Kong","sponsor_slug":"chinese-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04173650","publication_url":"https://clinicaltrials.gov/study/NCT04173650","title":"Mesenchymal Stem Cell Extracellular Vesicles for the Treatment of Recessive Dystrophic Epidermolysis Bullosa Wounds","has_exemption":false,"start_date":"2024-08-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Aegle Therapeutics","sponsor_slug":"aegle-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06992687","publication_url":"https://clinicaltrials.gov/study/NCT06992687","title":"A Phase I/II, Open-Label, Multicenter Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of HB0052 in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-09-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Shanghai Huaota Biopharmaceutical Co., Ltd.","sponsor_slug":"shanghai-huaota-biopharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260774","publication_url":"https://clinicaltrials.gov/study/NCT06260774","title":"A Phase 1/2 Multicenter, Open-Label, Dose-escalation and Expansion Study of TTX-MC138 in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2024-09-05","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"TransCode Therapeutics","sponsor_slug":"transcode-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06594887","publication_url":"https://clinicaltrials.gov/study/NCT06594887","title":"Use of Rectal Spacers for Proton Beam Radiation Therapy for Localized Prostate Cancer: Prospective Clinical Study","has_exemption":false,"start_date":"2024-09-06","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Princeton ProCure management, LLC.","sponsor_slug":"princeton-procure-management-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06599684","publication_url":"https://clinicaltrials.gov/study/NCT06599684","title":"Phase 2a Pilot, Open Label, Multicenter, Study of INV-102 Ophthalmic Solution in Subjects With Diabetic Macular Edema (DME) Associated With Non-proliferative Diabetic Retinopathy (NPDR)","has_exemption":false,"start_date":"2024-09-07","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Invirsa, Inc.","sponsor_slug":"invirsa-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05708755","publication_url":"https://clinicaltrials.gov/study/NCT05708755","title":"Cytomegalovirus T Cell Immunity and Antiviral Prophylaxis Minimization in Lung Transplant Recipients","has_exemption":false,"start_date":"2024-09-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"NYU Langone Health","sponsor_slug":"nyu-langone-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585540","publication_url":"https://clinicaltrials.gov/study/NCT06585540","title":"A Pilot Study to Evaluate Barhemsys for the Prevention of Postoperative Nausea And Vomiting in the Bariatric Surgery Population","has_exemption":false,"start_date":"2024-09-13","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Benaroya Research Institute","sponsor_slug":"benaroya-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06601803","publication_url":"https://clinicaltrials.gov/study/NCT06601803","title":"Effect of Surgiphor (sterile Povidone-Iodine) Wound Irrigation on Rate of Positive Deep Culture and NGS in Primary Total Shoulder Arthroplasty- a Prospective, Randomized Pilot Study","has_exemption":false,"start_date":"2024-09-16","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Rothman Institute Orthopaedics","sponsor_slug":"rothman-institute-orthopaedics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06607094","publication_url":"https://clinicaltrials.gov/study/NCT06607094","title":"Optimized Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia","has_exemption":false,"start_date":"2024-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","sponsor_slug":"the-affiliated-nanjing-drum-tower-hospital-of-nanjing-university-medical-school","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06569641","publication_url":"https://clinicaltrials.gov/study/NCT06569641","title":"Cardiac Surgery Recovery in Infants Assessed Using Neoneur Feeding System","has_exemption":false,"start_date":"2024-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Neoneur LLC","sponsor_slug":"neoneur-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06596590","publication_url":"https://clinicaltrials.gov/study/NCT06596590","title":"Modified Water Vapor Thermal Therapy (REZUM) in Management of Patients With Large-volume Benign Prostatic Hyperplasia","has_exemption":false,"start_date":"2024-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School","sponsor_slug":"the-affiliated-nanjing-drum-tower-hospital-of-nanjing-university-medical-school","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06634290","publication_url":"https://clinicaltrials.gov/study/NCT06634290","title":"Influence of Cemented Cephalic Augmentation on the Outcome of Osteosynthesis Using Intramedullary Nailing in the Surgical Treatment of Pertrochanteric Hip Fractures in the Elderly","has_exemption":false,"start_date":"2024-09-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Diego Matías Domínguez Prado","sponsor_slug":"diego-matias-dominguez-prado","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06624436","publication_url":"https://clinicaltrials.gov/study/NCT06624436","title":"Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia","has_exemption":false,"start_date":"2024-10-24","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Radboud University Medical Center","sponsor_slug":"radboud-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06069843","publication_url":"https://clinicaltrials.gov/study/NCT06069843","title":"KET-MCI: An Open-label Trial of Single-dose Ketamine Treatment to Improve Depression in Mild Cognitive Impairment","has_exemption":false,"start_date":"2024-11-01","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06627517","publication_url":"https://clinicaltrials.gov/study/NCT06627517","title":"Automated Insulin Delivery for Multiple Daily Injectors (AID4MDI)","has_exemption":false,"start_date":"2024-11-22","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Luna Diabetes","sponsor_slug":"luna-diabetes","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06662539","publication_url":"https://clinicaltrials.gov/study/NCT06662539","title":"A Randomized, Double-blind, Phase 2, Dose-finding Trial of Once Weekly Petrelintide Compared With Placebo in Participants With Obesity or Overweight With Weight Related Comorbidities","has_exemption":false,"start_date":"2024-12-09","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Zealand Pharma","sponsor_slug":"zealand-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06645873","publication_url":"https://clinicaltrials.gov/study/NCT06645873","title":"Comparison of Continuous Glucose Monitoring and Point-of-Care Measurements on the Intensive Care Unit: An Exploratory Study","has_exemption":false,"start_date":"2024-12-17","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Kim Kamphorst","sponsor_slug":"kim-kamphorst","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742229","publication_url":"https://clinicaltrials.gov/study/NCT06742229","title":"Prospective Clinical Data Collection for Developing Machine Learning-assisted Obstetric Ultrasound (MOBUS) Screening Algorithms","has_exemption":false,"start_date":"2024-12-20","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Caption Health, Inc.","sponsor_slug":"caption-health-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06835647","publication_url":"https://clinicaltrials.gov/study/NCT06835647","title":"Maternal Fetal Device Performance Testing During Antepartum Twin Monitoring","has_exemption":false,"start_date":"2025-01-21","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"GE Healthcare","sponsor_slug":"ge-healthcare","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06766435","publication_url":"https://clinicaltrials.gov/study/NCT06766435","title":"Evaluation of the Abbott i-STAT TBI Biomarker Test for Effect on Decreasing CT Utilization Among Adult Emergency Department Patients With Suspected Traumatic Brain Injury","has_exemption":false,"start_date":"2025-01-30","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06805942","publication_url":"https://clinicaltrials.gov/study/NCT06805942","title":"Embolization for the Treatment of Heel Pain Secondary to Plantar Fasciitis","has_exemption":false,"start_date":"2025-02-15","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"IR Centers","sponsor_slug":"ir-centers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06932146","publication_url":"https://clinicaltrials.gov/study/NCT06932146","title":"A Phase 2a Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamic (PD) Effects of LLX-424 in Patients With a History of Kidney Stones","has_exemption":false,"start_date":"2025-03-23","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Lilac Therapeutics, Inc.","sponsor_slug":"lilac-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06544564","publication_url":"https://clinicaltrials.gov/study/NCT06544564","title":"A Multi-Center, Prospective, Randomized Trial Evaluating the Efficacy of Membrane Wrap, A Human Amniotic Membrane on Venous Leg Ulcers in an Elderly Population","has_exemption":false,"start_date":"2025-03-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"BioLab Holdings","sponsor_slug":"biolab-holdings","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06890416","publication_url":"https://clinicaltrials.gov/study/NCT06890416","title":"A PHASE 3, MULTICENTER, PARALLEL-GROUP, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF RESPIRATORY SYNCYTIAL VIRUS PREFUSION F SUBUNIT VACCINE WHEN COADMINISTERED WITH HERPES ZOSTER SUBUNIT VACCINE IN ADULTS ≥50 YEARS OF AGE","has_exemption":false,"start_date":"2025-04-04","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06332781","publication_url":"https://clinicaltrials.gov/study/NCT06332781","title":"Intravesical Gentamicin to Prevent Recurrent UTI","has_exemption":false,"start_date":"2025-04-28","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Women and Infants Hospital of Rhode Island","sponsor_slug":"women-and-infants-hospital-of-rhode-island","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06975891","publication_url":"https://clinicaltrials.gov/study/NCT06975891","title":"Subjective and Objective Performance of Systane PRO Versus Refresh Optive Mega-3 in Dry Eye Patients","has_exemption":false,"start_date":"2025-05-15","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Scripps Poway Eyecare and Optometry","sponsor_slug":"scripps-poway-eyecare-and-optometry","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06971913","publication_url":"https://clinicaltrials.gov/study/NCT06971913","title":"Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia","has_exemption":false,"start_date":"2025-05-20","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Peking University People's Hospital","sponsor_slug":"peking-university-peoples-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06937216","publication_url":"https://clinicaltrials.gov/study/NCT06937216","title":"Evaluation of the Effectiveness of The Volara System Determined by Sputum Movement and Production","has_exemption":false,"start_date":"2025-05-31","completion_date":"2025-09-30","has_results":false,"results_due":false,"sponsor_name":"Baxter Healthcare Corporation","sponsor_slug":"baxter-healthcare-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03446547","publication_url":"https://clinicaltrials.gov/study/NCT03446547","title":"Ablative STEreotactic RadiOtherapy wIth Durvalumab (MEDI4736). An Open Label Randomized Phase II Trial With Durvalumab Following Stereotactic Body Radiotherapy (SBRT) in Patients With Stage I Non-small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2017-12-04","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Vastra Gotaland Region","sponsor_slug":"vastra-gotaland-region","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03305588","publication_url":"https://clinicaltrials.gov/study/NCT03305588","title":"RAD 1601: Pilot Trial of Frameless Virtual Cone Stereotactic Radiosurgical Thalamotomy for Intractable Tremor and Advanced Functional Connectivity Parcellation of the Thalamus","has_exemption":false,"start_date":"2017-12-05","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03456063","publication_url":"https://clinicaltrials.gov/study/NCT03456063","title":"A Phase III, Double-Blinded, Multicenter, Randomized Study Evaluating the Efficacy and Safety of Neoadjuvant Treatment With Atezolizumab or Placebo in Combination With Platinum-Based Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2018-04-24","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03684655","publication_url":"https://clinicaltrials.gov/study/NCT03684655","title":"Imaging Immune Activation in HIV Infection","has_exemption":false,"start_date":"2018-09-21","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"CellSight Technologies, Inc.","sponsor_slug":"cellsight-technologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04021537","publication_url":"https://clinicaltrials.gov/study/NCT04021537","title":"Transcutaneous Vagal Nerve Stimulation Improvement of Sleep Quality in Veterans With PTSD With or Without History of Mild TBI","has_exemption":false,"start_date":"2020-01-30","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04317105","publication_url":"https://clinicaltrials.gov/study/NCT04317105","title":"A Phase I/II Biomarker Driven Combination Trial of Copanlisib and Immune Checkpoint Inhibitors in Patients With Advanced Solid Tumors","has_exemption":false,"start_date":"2020-07-17","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07159490","publication_url":"https://clinicaltrials.gov/study/NCT07159490","title":"Lower Limb Prostheses for Individuals Who Carry Infants, Toddlers, and Other Loads","has_exemption":false,"start_date":"2020-12-03","completion_date":"2025-10-01","has_results":true,"results_due":false,"sponsor_name":"VA Puget Sound Health Care System","sponsor_slug":"va-puget-sound-health-care-system","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04380454","publication_url":"https://clinicaltrials.gov/study/NCT04380454","title":"Biomechanical and Neural Mechanisms of Post-stroke Gait Training","has_exemption":false,"start_date":"2021-03-16","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04658472","publication_url":"https://clinicaltrials.gov/study/NCT04658472","title":"A Phase 2, Multicenter, Open-label, Non-randomized, Proof-of-concept Study Evaluating the Efficacy, Safety, and Tolerability of SAR445088 in Adults With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)","has_exemption":false,"start_date":"2021-04-28","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Bioverativ - a sanofi company","sponsor_slug":"bioverativ-a-sanofi-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04968743","publication_url":"https://clinicaltrials.gov/study/NCT04968743","title":"Phase-dependent Evaluation of Motor Cortex Excitability With TMS in Stroke","has_exemption":false,"start_date":"2021-10-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05102864","publication_url":"https://clinicaltrials.gov/study/NCT05102864","title":"A Trial of Two-Week Brain Stimulation for Teenagers With ADHD","has_exemption":false,"start_date":"2021-10-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Bradley Hospital","sponsor_slug":"bradley-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05182489","publication_url":"https://clinicaltrials.gov/study/NCT05182489","title":"Lumbar Fusion With Micro and Nano-textured Titanium Interbody Cages - A Single-Blinded Randomized Controlled Trial Evaluating Adaptix™ Versus PEEK Cages","has_exemption":false,"start_date":"2021-11-19","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Ohio State University","sponsor_slug":"ohio-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05329194","publication_url":"https://clinicaltrials.gov/study/NCT05329194","title":"A Multicenter, Single-arm, Open-label, Post-Authorization, Phase 4 Effectiveness and Safety Study of Tezepelumab in Adult and Adolescent Participants With Severe Asthma Including Several Under-Studied Populations in the United States (PASSAGE)","has_exemption":false,"start_date":"2022-04-29","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05458128","publication_url":"https://clinicaltrials.gov/study/NCT05458128","title":"An Open-Label Study to Evaluate the Long-Term Safety and Effectiveness of Pitolisant in Adult Patients With Idiopathic Hypersomnia Who Completed Study HBS-101-CL-010","has_exemption":false,"start_date":"2022-08-19","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Harmony Biosciences Management, Inc.","sponsor_slug":"harmony-biosciences-management-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804344","publication_url":"https://clinicaltrials.gov/study/NCT05804344","title":"Establish the Role of Premotor and Motor Cortices in tDCS-facilitated Speech Motor Learning","has_exemption":false,"start_date":"2022-10-25","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"New York University","sponsor_slug":"new-york-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04826237","publication_url":"https://clinicaltrials.gov/study/NCT04826237","title":"Towards a Self-Administered Hearing Protection Regimen","has_exemption":false,"start_date":"2023-02-09","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06005168","publication_url":"https://clinicaltrials.gov/study/NCT06005168","title":"Comparison of a Morphomic-Based to the Standard-of-Care-Based Cefazolin Dose for Antimicrobial Prophylaxis","has_exemption":false,"start_date":"2023-03-08","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05157958","publication_url":"https://clinicaltrials.gov/study/NCT05157958","title":"Double Blind, Randomized, Phase II Clinical Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET Versus Vehicle Control in Dystrophic Epidermolysis Bullosa (DEB) Patients","has_exemption":false,"start_date":"2023-05-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Anterogen Co., Ltd.","sponsor_slug":"anterogen-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05936151","publication_url":"https://clinicaltrials.gov/study/NCT05936151","title":"A Phase 2b, Double-Blind Study to Investigate the Effect of Retatrutide on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes","has_exemption":false,"start_date":"2023-07-20","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06004986","publication_url":"https://clinicaltrials.gov/study/NCT06004986","title":"DUPI REDUCE Trial (DUPIlumab Dose REDUCtion in Patients With Controlled Atopic Eczema): a Multicenter, Low-intervention, Non-inferiority Randomized Controlled Trial, Embedded in the TREAT NL Registry","has_exemption":false,"start_date":"2023-08-14","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","sponsor_slug":"academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05957315","publication_url":"https://clinicaltrials.gov/study/NCT05957315","title":"Mobile Cardiac Outpatient Telemetry for Unexplained Syncope: Time to Treatment, Arrhythmia Diagnosis and Outcome","has_exemption":false,"start_date":"2023-09-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Carilion Clinic","sponsor_slug":"carilion-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06045689","publication_url":"https://clinicaltrials.gov/study/NCT06045689","title":"A Phase 3b, Open-label Study Evaluating the Efficacy and Safety of Luspatercept (BMS-986346/ACE-536) Initiated at Maximum Approved Dose in LR-MDS With IPSS-R Very Low-, Low-, or Intermediate-risk Who Require RBC Transfusions (MAXILUS)","has_exemption":false,"start_date":"2023-10-05","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06015308","publication_url":"https://clinicaltrials.gov/study/NCT06015308","title":"A Randomized, Double-blind, Placebo-controlled Phase 2 Study to Evaluate the Effect of Amlitelimab on Vaccine Antibody Responses in Adult Participants With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2023-10-06","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06333067","publication_url":"https://clinicaltrials.gov/study/NCT06333067","title":"Safety and Efficacy of SofWave Treatment to Lift Facial Lax Skin and Improve Facial Wrinkles Using Precise and Lift Applicators","has_exemption":false,"start_date":"2023-10-11","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Sofwave Medical LTD","sponsor_slug":"sofwave-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05695924","publication_url":"https://clinicaltrials.gov/study/NCT05695924","title":"Prospective Evaluation of Nanofibrillar Collagen Scaffold (BioBridge®) as an Adjunct to Lymph Node Transplant for Upper Extremity Lymphedema","has_exemption":false,"start_date":"2023-11-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Fibralign Corporation","sponsor_slug":"fibralign-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05223816","publication_url":"https://clinicaltrials.gov/study/NCT05223816","title":"An Open-Label, Multiple-Center, Phase IIa/IIb Clinical Trial to Evaluate the Efficacy, Safety and Tolerability of VG161 as Monotherapy and in Combination With Nivolumab for Treatment of Patients With Hepatocellular Carcinoma or Intrahepatic Cholangiocarcinoma","has_exemption":false,"start_date":"2024-01-24","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Virogin Biotech Canada Ltd","sponsor_slug":"virogin-biotech-canada-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06323174","publication_url":"https://clinicaltrials.gov/study/NCT06323174","title":"Efficacy and Safety of Co-administered Cagrilintide and Semaglutide (CagriSema) s.c. in Doses 2.4 mg/2.4 mg and 1.0 mg/1.0 mg Once Weekly Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Diet and Exercise","has_exemption":false,"start_date":"2024-03-19","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06317285","publication_url":"https://clinicaltrials.gov/study/NCT06317285","title":"A Phase 2, Randomized, Double-Blind, Placebo Controlled, Parallel Group Study (TRANSFORM) to Evaluate the Efficacy and Safety of GSK3915393 in Participants With Idiopathic Pulmonary Fibrosis (IPF)","has_exemption":false,"start_date":"2024-04-04","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06429176","publication_url":"https://clinicaltrials.gov/study/NCT06429176","title":"A Phase 2a, Randomized, Placebo-Controlled, Double Blind Multiple Ascending Dose Study in Patients with Cystic Fibrosis Carrying the 3849 +10 Kb C->T Mutation to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84","has_exemption":false,"start_date":"2024-06-24","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"SpliSense Ltd.","sponsor_slug":"splisense-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06489678","publication_url":"https://clinicaltrials.gov/study/NCT06489678","title":"The Benefit of Cone-beam Computed Tomography and Robotic Assisted Bronchoscopy for the Diagnosis of Peripheral Pulmonary Lesions and Other Lung Disease Requiring Lung Biopsy: An Open-label, Randomized, Controlled Trial.","has_exemption":false,"start_date":"2024-06-25","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Zurich","sponsor_slug":"university-of-zurich","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06542874","publication_url":"https://clinicaltrials.gov/study/NCT06542874","title":"Safety and Efficacy of Once-weekly Subcutaneous and Once-daily Oral NNC0487-0111 in Participants With Type 2 Diabetes - a Dose Finding Study","has_exemption":false,"start_date":"2024-08-07","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06625138","publication_url":"https://clinicaltrials.gov/study/NCT06625138","title":"Single-blinded Randomized Trial of Latex Vs Non-latex Hemorrhoid Banding","has_exemption":false,"start_date":"2024-08-30","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Huntington Memorial Hospital","sponsor_slug":"huntington-memorial-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07308912","publication_url":"https://clinicaltrials.gov/study/NCT07308912","title":"Biomodulatory Effects of GaAlAs 940 nm on Pain Control and Wound Healing at Palatal Donor Site Following Free Gingival Graft Harvesting: a Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2024-10-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"University of Medicine and Pharmacy at Ho Chi Minh City","sponsor_slug":"university-of-medicine-and-pharmacy-at-ho-chi-minh-city","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06338748","publication_url":"https://clinicaltrials.gov/study/NCT06338748","title":"Accuracy of the Dexcom G7 Continuous Glucose Monitoring System Following Cardiac Surgery","has_exemption":false,"start_date":"2024-11-02","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435845","publication_url":"https://clinicaltrials.gov/study/NCT06435845","title":"A Phase 2, Multicenter, Open-label Study to Evaluate the Pharmacokinetics and Safety of RLYB212 in Pregnant Women at Higher Risk for HPA-1a Alloimmunization","has_exemption":false,"start_date":"2024-11-21","completion_date":"2025-10-01","has_results":true,"results_due":false,"sponsor_name":"Rallybio","sponsor_slug":"rallybio","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06448676","publication_url":"https://clinicaltrials.gov/study/NCT06448676","title":"Head-to-Head Comparison of the Efficacy and Safety of All Five Commercially Available Botulinum Neurotoxin Type A Products for the Treatment of Glabellar Rhytides: A Multicenter, Triple-Blind, Randomized Controlled Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","sponsor_slug":"academisch-medisch-centrum-universiteit-van-amsterdam-amc-uva","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06818305","publication_url":"https://clinicaltrials.gov/study/NCT06818305","title":"A Multicenter, Open-Label, Factorial Design, Randomized Controlled Study to Explore the Efficacy and Safety of Finerenone and Empagliflozin, Alone or in Combination, in Delaying Renal Function Progression in High-Risk CKD Patients After Radical Nephrectomy for Renal Cell Carcinoma","has_exemption":false,"start_date":"2025-01-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Jinling Hospital, China","sponsor_slug":"jinling-hospital-china","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06914817","publication_url":"https://clinicaltrials.gov/study/NCT06914817","title":"Brillouin Microscopy Used to Evaluate Corneal Mechanical Properties in Patients With Corneal Dystrophies and Post-Corneal Surgery: a Pilot Study","has_exemption":false,"start_date":"2025-04-01","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Vienna Institute for Research in Ocular Surgery","sponsor_slug":"vienna-institute-for-research-in-ocular-surgery","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07054736","publication_url":"https://clinicaltrials.gov/study/NCT07054736","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 2 Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-08-31","completion_date":"2025-10-01","has_results":false,"results_due":false,"sponsor_name":"Zhejiang Kanova Biopharmaceutical Co., LTD","sponsor_slug":"zhejiang-kanova-biopharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05222906","publication_url":"https://clinicaltrials.gov/study/NCT05222906","title":"A Phase 3, Multicenter, Multinational, Randomized, Double-blind, Double-dummy, Active-comparator Study to Evaluate the Efficacy and Safety of Venglustat in Adult and Pediatric Patients With Gaucher Disease Type 3 (GD3) Who Have Reached Therapeutic Goals With Enzyme Replacement Therapy (ERT)","has_exemption":false,"start_date":"2022-04-18","completion_date":"2025-10-02","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05171686","publication_url":"https://clinicaltrials.gov/study/NCT05171686","title":"Association of Diuretics With Change in Extracellular Volume, Natriuretic Peptides, Symptoms, and Cardiovascular Outcomes in CKD","has_exemption":false,"start_date":"2023-02-01","completion_date":"2025-10-02","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05771480","publication_url":"https://clinicaltrials.gov/study/NCT05771480","title":"A Phase IIIb, Single Arm, Open-label, Multicentre Study of Durvalumab in Combination With Chemotherapy for the First Line Treatment for Patients With Advanced Biliary Tract Cancers (TOURMALINE)","has_exemption":false,"start_date":"2023-08-16","completion_date":"2025-10-02","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05989880","publication_url":"https://clinicaltrials.gov/study/NCT05989880","title":"Pilot Feasibility Trial of the SafeLM Supraglottic Airway","has_exemption":false,"start_date":"2023-09-19","completion_date":"2025-10-02","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06568003","publication_url":"https://clinicaltrials.gov/study/NCT06568003","title":"TRIal to Evaluate TraNsvenous TrIcuspid Valve ReplacemenT With LuX-Valve Plus System in Patients With Severe or Greater Tricuspid Regurgitation - SafetY and Clinical Performance","has_exemption":false,"start_date":"2024-09-26","completion_date":"2025-10-02","has_results":false,"results_due":false,"sponsor_name":"Jenscare Innovation Inc.","sponsor_slug":"jenscare-innovation-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07498153","publication_url":"https://clinicaltrials.gov/study/NCT07498153","title":"Spotting Syphilis: A Dual Point-of-Care Syphilis Screening Initiative in a Low-Resource Healthcare Setting","has_exemption":false,"start_date":"2025-09-30","completion_date":"2025-10-02","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04995081","publication_url":"https://clinicaltrials.gov/study/NCT04995081","title":"A Randomized, Double-Blind, Single Center, Phase 2, Efficacy and Safety Study of Allogeneic HB-adMSCs vs Placebo for the Treatment of Patients With Parkinson's Disease","has_exemption":false,"start_date":"2021-07-16","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"Hope Biosciences Research Foundation","sponsor_slug":"hope-biosciences-research-foundation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05429372","publication_url":"https://clinicaltrials.gov/study/NCT05429372","title":"A PHASE 2, MULTICENTER, SINGLE-ARM STUDY TO EVALUATE THE SAFETY AND DYSTROPHIN EXPRESSION AFTER FORDADISTROGENE MOVAPARVOVEC (PF-06939926) ADMINISTRATION IN MALE PARTICIPANTS WITH EARLY STAGE DUCHENNE MUSCULAR DYSTROPHY","has_exemption":false,"start_date":"2022-08-08","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223789","publication_url":"https://clinicaltrials.gov/study/NCT06223789","title":"VOLT-AF IDE Clinical Study","has_exemption":false,"start_date":"2024-04-03","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"Abbott Medical Devices","sponsor_slug":"abbott-medical-devices","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06403852","publication_url":"https://clinicaltrials.gov/study/NCT06403852","title":"Investigating Near-Threshold Perception During Anesthetic Sedation","has_exemption":false,"start_date":"2024-05-10","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06799845","publication_url":"https://clinicaltrials.gov/study/NCT06799845","title":"A Phase 2B, Randomized, Double Blind, Placebo and Active Comparator Controlled, Multicenter, Safety, and Efficacy Trial of ATX101 in Adults Undergoing Total Knee Arthroplasty","has_exemption":false,"start_date":"2025-02-03","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"Allay Therapeutics, Inc.","sponsor_slug":"allay-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07023822","publication_url":"https://clinicaltrials.gov/study/NCT07023822","title":"Women's Interventions for Sexual Health: WISH, Feasibility of a Factorial Design","has_exemption":false,"start_date":"2025-06-16","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"The University of Tennessee, Knoxville","sponsor_slug":"the-university-of-tennessee-knoxville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07190287","publication_url":"https://clinicaltrials.gov/study/NCT07190287","title":"Evaluation of a Wearable EEG-tFUS System for REM Sleep Modulation in Healthy Adults and Individuals With Subclinical Sleep Disturbances","has_exemption":false,"start_date":"2025-07-15","completion_date":"2025-10-03","has_results":false,"results_due":false,"sponsor_name":"University of Texas at Austin","sponsor_slug":"university-of-texas-at-austin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05900427","publication_url":"https://clinicaltrials.gov/study/NCT05900427","title":"A Double-Blind Randomized Comparison Trial of Postoperative Pain in Patients Undergoing Total Shoulder Arthroplasty Who Receive Interscalene Blocks With or Without Liposomal Bupivacaine (PoPTSAWoW Trial)","has_exemption":false,"start_date":"2023-09-08","completion_date":"2025-10-05","has_results":false,"results_due":false,"sponsor_name":"Johnny K. Lee","sponsor_slug":"johnny-k-lee","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06168799","publication_url":"https://clinicaltrials.gov/study/NCT06168799","title":"Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ilofotase Alfa in Patients at Risk for Renal Damage Following Open Heart Surgery","has_exemption":false,"start_date":"2023-12-19","completion_date":"2025-10-05","has_results":false,"results_due":false,"sponsor_name":"AM-Pharma","sponsor_slug":"am-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03692273","publication_url":"https://clinicaltrials.gov/study/NCT03692273","title":"A Within-Scar, Randomized Control Trial Comparing Fractional Ablative Carbon Dioxide Laser to Non-Energy-Based, Mechanical Tissue Extraction and No Treatment","has_exemption":false,"start_date":"2019-03-20","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04578756","publication_url":"https://clinicaltrials.gov/study/NCT04578756","title":"A 52-Week, Multicenter, Open-Label, Flexible-dose Study to Evaluate the Long-term Safety and Tolerability of Cariprazine in the Treatment of Pediatric Subjects With Schizophrenia, Bipolar I Disorder, or Autism Spectrum Disorder","has_exemption":false,"start_date":"2021-02-01","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04673617","publication_url":"https://clinicaltrials.gov/study/NCT04673617","title":"A Multi-Center, Open-Label, Phase 1/2 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-101 Monotherapy and AB-101 With Immunotherapy in Patients With Relapsed/Refractory Non-Hodgkin Lymphoma of B-Cell Origin.","has_exemption":false,"start_date":"2021-03-29","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Artiva Biotherapeutics, Inc.","sponsor_slug":"artiva-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05450692","publication_url":"https://clinicaltrials.gov/study/NCT05450692","title":"A Phase III, Open-label, Randomised, Multicentre Study of Ceralasertib Plus Durvalumab Versus Docetaxel in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Without Actionable Genomic Alterations, and Whose Disease Has Progressed On or After Prior Anti-PD-(L)1 Therapy and Platinum-based Chemotherapy: LATIFY","has_exemption":false,"start_date":"2022-09-15","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05317936","publication_url":"https://clinicaltrials.gov/study/NCT05317936","title":"Pirtobrutinib (LOXO-305) Consolidation for MRD Eradication in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL) Treated With Venetoclax","has_exemption":false,"start_date":"2022-11-16","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05900986","publication_url":"https://clinicaltrials.gov/study/NCT05900986","title":"An Open-label, Single-arm, Phase 1b/2 Study to Investigate the Safety, Efficacy and Pharmacokinetics of LS301-IT in Female Patients Undergoing Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for Ductal Carcinoma in Situ (DCIS) or Stage I-II Primary Invasive Breast Cancer","has_exemption":false,"start_date":"2023-07-14","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Integro Theranostics","sponsor_slug":"integro-theranostics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05715281","publication_url":"https://clinicaltrials.gov/study/NCT05715281","title":"Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 3 Tiragolumab + Atezolizumab","has_exemption":false,"start_date":"2023-09-26","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06225362","publication_url":"https://clinicaltrials.gov/study/NCT06225362","title":"Evaluation and Clinical Outcomes After Routine Cataract Surgery With the Quatera® 700 and the Centurion® Vision System","has_exemption":false,"start_date":"2024-01-10","completion_date":"2025-10-06","has_results":true,"results_due":false,"sponsor_name":"Carolina Eyecare Physicians, LLC","sponsor_slug":"carolina-eyecare-physicians-llc","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT05891613","publication_url":"https://clinicaltrials.gov/study/NCT05891613","title":"Liposomal Bupivacaine Versus 0.25% Bupivacaine Hydrochloride for Postoperative Analgesia After Breast Reduction Surgery: A Prospective, Single Blind, Non-randomized Controlled Trial","has_exemption":false,"start_date":"2024-01-24","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06237426","publication_url":"https://clinicaltrials.gov/study/NCT06237426","title":"A 52-Week, Open-Label Evaluation of the Long-term Efficacy and Safety of Single and Repeated Treatments With Methylone for the Treatment of PTSD IMPACT-EXT (Investigation of Methylone for Post-Traumatic Stress Disorder [PTSD])","has_exemption":false,"start_date":"2024-03-06","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Transcend Therapeutics","sponsor_slug":"transcend-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06475677","publication_url":"https://clinicaltrials.gov/study/NCT06475677","title":"Prospective Trial of the OrthoCor Advanced System for Patients With Knee Osteoarthritis","has_exemption":false,"start_date":"2024-06-18","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Caerus Corporation","sponsor_slug":"caerus-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06637761","publication_url":"https://clinicaltrials.gov/study/NCT06637761","title":"Clinical and Radio-graphic Evaluation of Bio-active Bio-ceramic (Neo MTA 2) Versus White MTA Used as Coronal Plug Material in Revascularization of Non-vital Immature Permanent Anterior Teeth: A Randomized Clinical Trial","has_exemption":false,"start_date":"2024-10-05","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Cairo University","sponsor_slug":"cairo-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06660173","publication_url":"https://clinicaltrials.gov/study/NCT06660173","title":"A Study to Evaluate the Efficacy, Safety & Tolerability of Maridebart Cafraglutide in Adults With T2DM","has_exemption":false,"start_date":"2024-11-07","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06804603","publication_url":"https://clinicaltrials.gov/study/NCT06804603","title":"A Proof of Concept, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight Class I or Class II Obese Volunteers","has_exemption":false,"start_date":"2025-02-25","completion_date":"2025-10-06","has_results":false,"results_due":false,"sponsor_name":"Vanda Pharmaceuticals","sponsor_slug":"vanda-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03564873","publication_url":"https://clinicaltrials.gov/study/NCT03564873","title":"Concomitant Omacetaxine Mepesuccinate and Azacitidine for Patients With Previously Untreated High Grade Myelodysplastic Syndromes","has_exemption":false,"start_date":"2018-09-17","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"University of Colorado, Denver","sponsor_slug":"university-of-colorado-denver","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04006522","publication_url":"https://clinicaltrials.gov/study/NCT04006522","title":"An Exploratory Study of 89Zr-DFO-Atezolizumab ImmunoPET/CT in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2019-10-02","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"James Brugarolas","sponsor_slug":"james-brugarolas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04273945","publication_url":"https://clinicaltrials.gov/study/NCT04273945","title":"A Phase 3, Prospective, Multicenter, Double-blind, Double-dummy, Randomized, Active-controlled, Parallel-group, Group-sequential, Adaptive, Event-driven Study to Compare Efficacy, Safety, and Tolerability of Macitentan 75 mg Versus Macitentan 10 mg in Patients With Pulmonary Arterial Hypertension, Followed by an Open-label Treatment Period With Macitentan 75 mg","has_exemption":false,"start_date":"2020-06-30","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"Actelion","sponsor_slug":"actelion","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05484492","publication_url":"https://clinicaltrials.gov/study/NCT05484492","title":"Ridge Preservation Comparing the Clinical and Histologic Healing of Two Different Putty Bone Grafts","has_exemption":false,"start_date":"2022-10-06","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"University of Louisville","sponsor_slug":"university-of-louisville","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06149520","publication_url":"https://clinicaltrials.gov/study/NCT06149520","title":"A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Assess the Efficacy and Safety of BAY 3018250 in Patients With Symptomatic Proximal Deep Vein Thrombosis","has_exemption":false,"start_date":"2024-01-15","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06742957","publication_url":"https://clinicaltrials.gov/study/NCT06742957","title":"A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multiple-Site, Clinical Study to Evaluate the Therapeutic Equivalence of Tapinarof Cream 1% (Teva Pharmaceuticals, Inc.) With VTAMA® Tapinarof (Tapinarof) Cream 1% (Dermavant Sciences, Inc.) in Adult Patients With Plaque Psoriasis","has_exemption":false,"start_date":"2024-12-17","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"Teva Pharmaceuticals USA","sponsor_slug":"teva-pharmaceuticals-usa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07116694","publication_url":"https://clinicaltrials.gov/study/NCT07116694","title":"Assessment of Acute Psychomotor Agitation Measures Associated With Schizophrenia and Bipolar Disorder","has_exemption":false,"start_date":"2025-06-19","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"BioXcel Therapeutics Inc","sponsor_slug":"bioxcel-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07287111","publication_url":"https://clinicaltrials.gov/study/NCT07287111","title":"Multi-Reader Multi-Case, Cross-Over, Retrospective Study to Evaluate the Effectiveness of CadAI-B Dx for Decision Support in Breast Ultrasound","has_exemption":false,"start_date":"2025-08-30","completion_date":"2025-10-07","has_results":false,"results_due":false,"sponsor_name":"BeamWorks Inc.","sponsor_slug":"beamworks-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03869190","publication_url":"https://clinicaltrials.gov/study/NCT03869190","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatments and Combinations in Patients With Urothelial Carcinoma (MORPHEUS-UC)","has_exemption":false,"start_date":"2019-06-01","completion_date":"2025-10-08","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03887936","publication_url":"https://clinicaltrials.gov/study/NCT03887936","title":"Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism","has_exemption":false,"start_date":"2019-10-01","completion_date":"2025-10-08","has_results":true,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT03978442","publication_url":"https://clinicaltrials.gov/study/NCT03978442","title":"CPT-SMART for Treatment of PTSD and Cigarette Smoking","has_exemption":false,"start_date":"2019-11-07","completion_date":"2025-10-08","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05856448","publication_url":"https://clinicaltrials.gov/study/NCT05856448","title":"A Randomized, Double-blind, Placebo-controlled, Multicenter Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Orally Administered GLPG3667 in Adult Subjects With Active Systemic Lupus Erythematosus","has_exemption":false,"start_date":"2023-06-28","completion_date":"2025-10-08","has_results":false,"results_due":false,"sponsor_name":"Galapagos NV","sponsor_slug":"galapagos-nv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07140380","publication_url":"https://clinicaltrials.gov/study/NCT07140380","title":"Phase 2b, Proof-of-Concept, Single-center, Double-Masked, Randomized Study Comparing the Safety, Tolerability, and Efficacy of Three Different Ophthalmic Eyelid Wipe Dosing Techniques Using IVW-1001 in Subjects With Dry Eye Disease","has_exemption":false,"start_date":"2025-08-20","completion_date":"2025-10-08","has_results":false,"results_due":false,"sponsor_name":"IVIEW Therapeutics Inc.","sponsor_slug":"iview-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03281369","publication_url":"https://clinicaltrials.gov/study/NCT03281369","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Cancer or Esophageal Cancer (Morpheus-Gastric and Esophageal Cancer)","has_exemption":false,"start_date":"2017-10-13","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03790332","publication_url":"https://clinicaltrials.gov/study/NCT03790332","title":"Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)","has_exemption":false,"start_date":"2018-11-19","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Pharmacyclics LLC.","sponsor_slug":"pharmacyclics-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03622775","publication_url":"https://clinicaltrials.gov/study/NCT03622775","title":"Daratumumab-Based Maintenance in Patients With Relapsed Multiple Myeloma After Salvage Autologous Stem Cell Transplantation","has_exemption":false,"start_date":"2019-04-11","completion_date":"2025-10-09","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04488133","publication_url":"https://clinicaltrials.gov/study/NCT04488133","title":"A Phase 4 Study of Nusinersen (BIIB058) Among Patients With Spinal Muscular Atrophy Who Received Onasemnogene Abeparvovec","has_exemption":false,"start_date":"2021-01-04","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04861259","publication_url":"https://clinicaltrials.gov/study/NCT04861259","title":"A Phase III, Multicenter, Single-Arm Study Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Crovalimab in Adult and Adolescent Patients With Atypical Hemolytic Uremic Syndrome (aHUS)","has_exemption":false,"start_date":"2021-10-22","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05105841","publication_url":"https://clinicaltrials.gov/study/NCT05105841","title":"A Phase 2 Study of the Safety and Efficacy of Venetoclax in Combination With Obinutuzumab or Ibrutinib in Japanese Subjects With Previously Untreated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)","has_exemption":false,"start_date":"2021-11-08","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06028230","publication_url":"https://clinicaltrials.gov/study/NCT06028230","title":"A Parallel-group Treatment, Phase 2, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of SAR444656 in Adult Participants With Moderate to Severe Hidradenitis Suppurativa","has_exemption":false,"start_date":"2023-09-29","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06256328","publication_url":"https://clinicaltrials.gov/study/NCT06256328","title":"A Randomized, Multicenter, Double-blind, Phase II Study to Compare the Efficacy and Safety of the Treatment With ONO-4578 in Combination With Nivolumab, Fluoropyrimidine-based and Platinum- Based Chemotherapy (Hereinafter Referred to as Chemotherapy) With Those of the Treatment With Placebo in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)","has_exemption":false,"start_date":"2024-01-10","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Ono Pharmaceutical Co. Ltd","sponsor_slug":"ono-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06071715","publication_url":"https://clinicaltrials.gov/study/NCT06071715","title":"Cryoanalgesia to Treat Phantom Limb Pain Following a Trans-Femoral (Above-Knee) Amputation: A Randomized, Sham-Controlled Pilot Study","has_exemption":false,"start_date":"2024-02-12","completion_date":"2025-10-09","has_results":true,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT06309992","publication_url":"https://clinicaltrials.gov/study/NCT06309992","title":"Multicentre, Randomised, Double-blind, Placebo-controlled, 48-week, Phase III Trial to Evaluate the Efficacy and Safety of Survodutide Administered Subcutaneously in Participants With Overweight or Obesity and Presumed or Confirmed Nonalcoholic Steatohepatitis (NASH)","has_exemption":true,"start_date":"2024-04-02","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06563804","publication_url":"https://clinicaltrials.gov/study/NCT06563804","title":"Phase 1/2 Clinical Trial of S227928, an Anti-CD74 Antibody-Drug Conjugate Targeting MCL-1, as a Single Agent and in Combination With Venetoclax in Patients With Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)/AML, or Chronic Myelomonocytic Leukemia (CMML)","has_exemption":false,"start_date":"2025-02-25","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Servier Bio-Innovation LLC","sponsor_slug":"servier-bio-innovation-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06822517","publication_url":"https://clinicaltrials.gov/study/NCT06822517","title":"A Randomized, Double-Blind, Placebo-Controlled, Phase 1b Study of the NLRP3 Inhibitor VENT-02 in Patients With Mild to Moderate Parkinson's Disease","has_exemption":false,"start_date":"2025-03-05","completion_date":"2025-10-09","has_results":false,"results_due":false,"sponsor_name":"Ventus Therapeutics U.S., Inc.","sponsor_slug":"ventus-therapeutics-us-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03911557","publication_url":"https://clinicaltrials.gov/study/NCT03911557","title":"Phase 2 Investigation of MEDI4736 (Durvalumab) and Tremelimumab Combination in Somatically Hypermutated Recurrent Solid Tumors","has_exemption":false,"start_date":"2019-06-08","completion_date":"2025-10-10","has_results":false,"results_due":false,"sponsor_name":"John L. Villano, MD, PhD","sponsor_slug":"john-l-villano-md-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04668885","publication_url":"https://clinicaltrials.gov/study/NCT04668885","title":"Lower Doses of CPX-351 as a Novel Approach for the Treatment of Older Patients With Relapsed or Refractory Acute Myeloid Leukemia and Myelodysplastic Syndromes","has_exemption":false,"start_date":"2021-01-14","completion_date":"2025-10-10","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06215144","publication_url":"https://clinicaltrials.gov/study/NCT06215144","title":"A Phase 2/3 Randomized Double-Blind Placebo Controlled Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR in Pediatric Subjects With Attention-Deficit/Hyperactivity Disorder","has_exemption":false,"start_date":"2024-01-25","completion_date":"2025-10-10","has_results":false,"results_due":false,"sponsor_name":"Neurocentria, Inc.","sponsor_slug":"neurocentria-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06215911","publication_url":"https://clinicaltrials.gov/study/NCT06215911","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Dose Finding Study to Assess the Safety and Effectiveness of Tovinontrine in Patients With Chronic Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2024-02-13","completion_date":"2025-10-10","has_results":false,"results_due":false,"sponsor_name":"Cardurion Pharmaceuticals, Inc.","sponsor_slug":"cardurion-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07056036","publication_url":"https://clinicaltrials.gov/study/NCT07056036","title":"Safety and Efficacy of BTL-699-2 for the Improvement in Willpower, Self-control & Food Cravings","has_exemption":false,"start_date":"2024-11-01","completion_date":"2025-10-10","has_results":false,"results_due":false,"sponsor_name":"BTL Industries Ltd.","sponsor_slug":"btl-industries-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05684978","publication_url":"https://clinicaltrials.gov/study/NCT05684978","title":"Efficacy and Safety of Perampanel in the Treatment of Refractory Status Epilepticus","has_exemption":false,"start_date":"2025-10-10","completion_date":"2025-10-10","has_results":false,"results_due":false,"sponsor_name":"Wayne State University","sponsor_slug":"wayne-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04815876","publication_url":"https://clinicaltrials.gov/study/NCT04815876","title":"Randomized Trial Comparing Transperineal vs. Transrectal MRI-targeted Prostate Biopsy; Randomized Controlled Trial Assessing Transperineal Prostate Biopsy to Reduce Infection Complications","has_exemption":false,"start_date":"2021-06-24","completion_date":"2025-10-11","has_results":false,"results_due":false,"sponsor_name":"Weill Medical College of Cornell University","sponsor_slug":"weill-medical-college-of-cornell-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03520686","publication_url":"https://clinicaltrials.gov/study/NCT03520686","title":"Phase 3, Open-Label, 4-Cohort Study of Nogapendekin Alfa Inbakicept in Combination With Current Standard of Care as First-Line Treatment for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2018-05-18","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03856216","publication_url":"https://clinicaltrials.gov/study/NCT03856216","title":"Addition of Inotuzumab Ozogamicin Pre- and Post-Allogeneic Transplantation","has_exemption":false,"start_date":"2019-10-28","completion_date":"2025-10-13","has_results":true,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04386993","publication_url":"https://clinicaltrials.gov/study/NCT04386993","title":"De-escalated Conformal Radiation Expedited Sequentially With Chemotherapy for Endometrial Cancer (DeCRESCEndo)","has_exemption":false,"start_date":"2020-07-07","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04390399","publication_url":"https://clinicaltrials.gov/study/NCT04390399","title":"Open-label, Randomized, Comparative Phase 2 Study of Combination Immunotherapy Plus Standard-of-care Chemotherapy Versus Standard-of-care Chemotherapy for the Treatment of Locally Advanced or Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2020-07-21","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"ImmunityBio, Inc.","sponsor_slug":"immunitybio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04628494","publication_url":"https://clinicaltrials.gov/study/NCT04628494","title":"A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL)","has_exemption":false,"start_date":"2021-01-13","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07226752","publication_url":"https://clinicaltrials.gov/study/NCT07226752","title":"A Randomized, Open-Label, Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma","has_exemption":false,"start_date":"2022-10-08","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Genmab","sponsor_slug":"genmab","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05695950","publication_url":"https://clinicaltrials.gov/study/NCT05695950","title":"A Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Orally Administered GLPG3667 Once Daily for 24 Weeks in Adult Subjects With Dermatomyositis","has_exemption":false,"start_date":"2023-02-27","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Galapagos NV","sponsor_slug":"galapagos-nv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05705349","publication_url":"https://clinicaltrials.gov/study/NCT05705349","title":"A Phase 3, Randomized, Active-Controlled, Double-Blind Clinical Study to Evaluate the Antiretroviral Activity, Safety, and Tolerability of Doravirine/Islatravir (DOR/ISL 100 mg/0.25 mg) Once-Daily in HIV-1 Infected Treatment-Naïve Participants","has_exemption":false,"start_date":"2023-03-08","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05572515","publication_url":"https://clinicaltrials.gov/study/NCT05572515","title":"A Phase 3 Randomized Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma Who Have Received 1 to 3 Prior Lines of Therapy, Including an Anti-CD38 Monoclonal Antibody and Lenalidomide","has_exemption":false,"start_date":"2023-03-29","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05994703","publication_url":"https://clinicaltrials.gov/study/NCT05994703","title":"Assisting Smokers to Switch to an e-Cigarette by Accelerating Learning of Adaptive Habits Using D-cycloserine","has_exemption":false,"start_date":"2023-10-20","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Rose Research Center, LLC","sponsor_slug":"rose-research-center-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06305806","publication_url":"https://clinicaltrials.gov/study/NCT06305806","title":"RECOVER-AUTONOMIC (Ivabradine): Randomized Trial of the Effect of Ivabradine Versus Placebo on Long COVID Symptoms","has_exemption":false,"start_date":"2024-03-11","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Kanecia Obie Zimmerman","sponsor_slug":"kanecia-obie-zimmerman","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05999747","publication_url":"https://clinicaltrials.gov/study/NCT05999747","title":"A Phase 3, Multicenter, Prospective, Randomized, Open-label Study for Intraoperative Ureter(s) Visualization When Using ASP5354 With Near-infrared Fluorescence (NIR-F) Imaging in Adult Participants Undergoing Minimally Invasive and Open Abdominopelvic Surgeries","has_exemption":false,"start_date":"2024-03-19","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Astellas Pharma Global Development, Inc.","sponsor_slug":"astellas-pharma-global-development-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05997225","publication_url":"https://clinicaltrials.gov/study/NCT05997225","title":"Preventing Lung Cancer Through Tobacco Cessation at FDNY","has_exemption":false,"start_date":"2024-05-31","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06648655","publication_url":"https://clinicaltrials.gov/study/NCT06648655","title":"A Phase 2, Randomized, Investigator and Participant bLInded, placeBo-controllEd, paRallel-group Study to Investigate the sAfety, Tolerability, and Preliminary Efficacy of TMP-301 TrEatment in Adult Patients With Alcohol Use Disorder (AUD)","has_exemption":false,"start_date":"2024-11-14","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"Tempero Bio, Inc.","sponsor_slug":"tempero-bio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06864143","publication_url":"https://clinicaltrials.gov/study/NCT06864143","title":"A Phase 2, Randomized, Observer-blind, Active-control Study to Evaluate the Immunogenicity, Reactogenicity, and Safety of mRNA-1083 (Influenza and COVID-19) Vaccine in Adults ≥18 to <65 Years of Age","has_exemption":false,"start_date":"2025-03-07","completion_date":"2025-10-13","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03036488","publication_url":"https://clinicaltrials.gov/study/NCT03036488","title":"A Phase III, Randomized, Double-blind Study to Evaluate Pembrolizumab Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy for Triple Negative Breast Cancer (TNBC)","has_exemption":false,"start_date":"2017-03-07","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03337698","publication_url":"https://clinicaltrials.gov/study/NCT03337698","title":"A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Non-Small Cell Lung Cancer (Morpheus-Lung)","has_exemption":false,"start_date":"2017-12-27","completion_date":"2025-10-14","has_results":true,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"reported","is_pact":false,"days_late":null},{"registry_id":"NCT04157985","publication_url":"https://clinicaltrials.gov/study/NCT04157985","title":"Evaluating Length of Treatment With PD-1/PD-L1 Inhibitor in Advanced Solid Tumors","has_exemption":false,"start_date":"2019-11-15","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Dan Zandberg","sponsor_slug":"dan-zandberg","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04641442","publication_url":"https://clinicaltrials.gov/study/NCT04641442","title":"A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations","has_exemption":false,"start_date":"2020-12-18","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04373642","publication_url":"https://clinicaltrials.gov/study/NCT04373642","title":"A Single-arm Phase II Trial of Palliative \"QUAD SHOT\" Radiotherapy Combined With Pembrolizumab in Patients With Recurrent Head & Neck Cancer","has_exemption":false,"start_date":"2020-12-23","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"University of Oklahoma","sponsor_slug":"university-of-oklahoma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05111626","publication_url":"https://clinicaltrials.gov/study/NCT05111626","title":"A Phase 1b/3 Study of Bemarituzumab Plus Chemotherapy and Nivolumab Versus Chemotherapy and Nivolumab Alone in Subjects With Previously Untreated Advanced Gastric and Gastroesophageal Junction Cancer With FGFR2b Overexpression","has_exemption":false,"start_date":"2022-03-14","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06051721","publication_url":"https://clinicaltrials.gov/study/NCT06051721","title":"A Phase 2a, Randomized, Double-Blind, Active-Controlled Study to Assess the Preliminary Clinical Efficacy, Safety, Tolerability, and Pharmacokinetics, of CYB004 in Participants With Generalized Anxiety Disorder (GAD)","has_exemption":false,"start_date":"2024-05-10","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Cybin IRL Limited","sponsor_slug":"cybin-irl-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06591598","publication_url":"https://clinicaltrials.gov/study/NCT06591598","title":"An Open-label, Non-randomized, Multi-center, Phase 4 Pharmacokinetic Study to Evaluate the Systemic Exposure After Bilateral Intravitreal Administration of High Dose (8 mg) Aflibercept in Adults With Diabetic Macular Edema or Neovascular Age-related Macular Degeneration","has_exemption":false,"start_date":"2024-09-02","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Bayer","sponsor_slug":"bayer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06631482","publication_url":"https://clinicaltrials.gov/study/NCT06631482","title":"Randomized Controlled Trial Comparing HPI and Elevated Threshold Monitor Alarms in Preventing Intraoperative Hypotension","has_exemption":false,"start_date":"2024-09-16","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"National Taiwan University Hospital","sponsor_slug":"national-taiwan-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07350187","publication_url":"https://clinicaltrials.gov/study/NCT07350187","title":"Prospective, Randomized, Controlled Trial Comparing Self-Gripping and Conventional Mesh in Laparoscopic Totally Extra Peritoneal Inguinal Hernia Repair","has_exemption":false,"start_date":"2024-10-22","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Chungnam National University Hospital","sponsor_slug":"chungnam-national-university-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06654271","publication_url":"https://clinicaltrials.gov/study/NCT06654271","title":"Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT Using Integrated Intraprocedural Imaging: the RELIANT 2 Trial","has_exemption":false,"start_date":"2024-11-11","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07149376","publication_url":"https://clinicaltrials.gov/study/NCT07149376","title":"Clinical Investigation to Assess the Efficacy of a Toothpaste Containing 8% Arginine as Compared to Colgate Cavity Protection Toothpaste in the Reduction of Dentinal Hypersensitivity.","has_exemption":false,"start_date":"2025-08-18","completion_date":"2025-10-14","has_results":false,"results_due":false,"sponsor_name":"Colgate Palmolive","sponsor_slug":"colgate-palmolive","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03341078","publication_url":"https://clinicaltrials.gov/study/NCT03341078","title":"Brain Function and Connectivity in Methamphetamine Dependence: The Link to Neuroinflammation and the Effects of Ibudilast","has_exemption":false,"start_date":"2019-05-01","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03900468","publication_url":"https://clinicaltrials.gov/study/NCT03900468","title":"Medtronic Deep Brain Stimulation (DBS) Therapy for Epilepsy Post-Approval Study (EPAS)","has_exemption":false,"start_date":"2020-03-05","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"MedtronicNeuro","sponsor_slug":"medtronicneuro","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04243499","publication_url":"https://clinicaltrials.gov/study/NCT04243499","title":"A First-in-human, Two-part Clinical Study to Assess the Safety, Tolerability and Activity of IV Doses of ICT01 as Monotherapy and in Combination With a Checkpoint Inhibitor, in Patients With Advanced-stage, Relapsed/Refractory Cancer","has_exemption":false,"start_date":"2020-03-05","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"ImCheck Therapeutics","sponsor_slug":"imcheck-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04599218","publication_url":"https://clinicaltrials.gov/study/NCT04599218","title":"MR/TRUS Fusion Guided Prostate Biopsy - An Improved Way to Detect and Quantify Prostate Cancer","has_exemption":false,"start_date":"2020-08-21","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Ardeshir Rastinehad","sponsor_slug":"ardeshir-rastinehad","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04848519","publication_url":"https://clinicaltrials.gov/study/NCT04848519","title":"Immune Checkpoint Inhibitors With or Without Propranolol Hydrochloride In Patients With Urothelial Carcinoma","has_exemption":false,"start_date":"2021-05-20","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04557956","publication_url":"https://clinicaltrials.gov/study/NCT04557956","title":"Phase 1/2 Study of an EZH2 Inhibitor (Tazemetostat) in Combination With Dual BRAF/MEK Inhibition in Patients With BRAF- Mutated Metastatic Melanoma Who Progressed on Prior BRAF/MEK Inhibitor Therapy","has_exemption":false,"start_date":"2021-08-19","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04633005","publication_url":"https://clinicaltrials.gov/study/NCT04633005","title":"Polypill Strategy for the Evidence-Based Management of Heart Failure With Reduced Ejection Fraction in an Underserved Patient Population","has_exemption":false,"start_date":"2021-11-15","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05198804","publication_url":"https://clinicaltrials.gov/study/NCT05198804","title":"A Phase 1/2 Dose-Escalation and Dose-Expansion Study of ZN-c3 in Combination With Niraparib and ZN-c3 Monotherapy in Subjects With Platinum-Resistant Ovarian Cancer","has_exemption":false,"start_date":"2022-01-27","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc","sponsor_slug":"k-group-beta-inc-a-wholly-owned-subsidiary-of-zentalis-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05032040","publication_url":"https://clinicaltrials.gov/study/NCT05032040","title":"A Phase 2 Study of XmAb20717 in Patients With Selected Gynecological Malignancies and Metastatic Castration-Resistant Prostate Cancer","has_exemption":false,"start_date":"2022-07-21","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Xencor, Inc.","sponsor_slug":"xencor-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05900050","publication_url":"https://clinicaltrials.gov/study/NCT05900050","title":"A Phase 2a, Open-label, Randomized, Controlled, Multi-center Proof of Concept Study to Assess the Efficacy, Safety, and Tolerability of VS-01 on Top of Standard of Care, Compared to Standard of Care Alone, in Adult Patients With Acute-on-chronic Liver Failure (ACLF)","has_exemption":false,"start_date":"2023-07-02","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Genfit","sponsor_slug":"genfit","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05771584","publication_url":"https://clinicaltrials.gov/study/NCT05771584","title":"A Phase 2 Study to Evaluate the Safety and Immunological Efficacy of Therapeutic Cancer Vaccine (AST-301, pNGVL3-hICD) in Patients With HER2 Expressing Gastric Cancer (CORNERSTONE-003)","has_exemption":false,"start_date":"2023-07-04","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Aston Sci. Inc.","sponsor_slug":"aston-sci-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05726227","publication_url":"https://clinicaltrials.gov/study/NCT05726227","title":"Long-term Safety and Efficacy of Semaglutide s.c. Once-weekly on Weight Management in Children and Adolescents (Aged 6 to <18 Years) With Obesity or Overweight","has_exemption":false,"start_date":"2023-07-07","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Novo Nordisk A/S","sponsor_slug":"novo-nordisk-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06323356","publication_url":"https://clinicaltrials.gov/study/NCT06323356","title":"A Phase 3, Open-Label, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-279 in Adult Subjects With Generalized Pustular Psoriasis or Erythrodermic Psoriasis","has_exemption":false,"start_date":"2024-03-19","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06342973","publication_url":"https://clinicaltrials.gov/study/NCT06342973","title":"Horizontal Ridge Augmentation With Demineralized Bone Allograft Layered With Xenograft - a Prospective Clinical Study","has_exemption":false,"start_date":"2024-03-27","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Louisiana State University Health Sciences Center in New Orleans","sponsor_slug":"louisiana-state-university-health-sciences-center-in-new-orleans","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06435273","publication_url":"https://clinicaltrials.gov/study/NCT06435273","title":"A Randomised, Double-blind, Parallel Group, Placebo Controlled, 4-Week, Phase II Study to Evaluate the Effect of AZD4604 on Airway Inflammation and Biomarkers in Adults With Asthma","has_exemption":false,"start_date":"2024-08-05","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06236711","publication_url":"https://clinicaltrials.gov/study/NCT06236711","title":"A Feasibility Study of Transcranial Direct Current Stimulation (tDCS) as an Adjunctive Treatment for Treatment Resistant Depression (TRD) in Hospitalized Patients","has_exemption":false,"start_date":"2025-03-20","completion_date":"2025-10-15","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null}]}